Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(716).63.Maxillofacial And Orthodontic Medicine Department Case No 01. đ˜ŧđ™Ĩ𝙝𝙩𝙝𝙤đ™Ē𝙨 đ™Ē𝙡𝙘𝙚𝙧𝙨

Defination :- āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous Ulcers) āĻšāϞ āĻŽā§āĻ–āĻ—āĻšā§āĻŦāϰ⧇āϰ āĻ­āĻŋāϤāϰ⧇ āϘāĻŸā§‡ āĻāĻŽāύ āϛ⧋āϟ āĻ•ā§āώāϤ āĻŦāĻž āϘāĻž, āϝāĻž āϏāĻžāϧāĻžāϰāĻŖāϤ āϖ⧁āĻŦ āϝāĻ¨ā§āĻ¤ā§āϰāĻŖāĻžāĻĻāĻžāϝāĻŧāĻ• āĻšāϝāĻŧāĨ¤ āĻāϗ⧁āϞāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ—āĻžāϞ⧇āϰ āĻ­āĻŋāϤāϰ⧇āϰ āĻ…āĻ‚āĻļ, āϜāĻŋāĻšā§āĻŦāĻž, āĻ ā§‹āρāĻŸā§‡āϰ āϭ⧇āϤāϰ⧇āϰ āĻĻāĻŋāϕ⧇ āĻŦāĻž āĻŽā§āϖ⧇āϰ āĻŽā§‡āĻā§‡āϤ⧇ (palate) āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧāĨ¤ āĻāϗ⧁āϞāĻŋāϰ āφāĻ•āĻžāϰ āϛ⧋āϟ, āϏāĻžāĻĻāĻž āĻŦāĻž āĻšāϞ⧁āĻĻ āϰāϙ⧇āϰ āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇, āĻāĻŦāĻ‚ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϞāĻžāϞ āφāĻŦāϰāĻŖ āĻĨāĻžāϕ⧇āĨ¤

Cause:-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ (Aphthous Ulcers) āĻ•āĻžāϰāĻŖāϏāĻŽā§‚āĻš āĻŦāĻŋāώāϝāĻŧ⧇ Davidson’s Principles and Practice of Medicine-āĻ āϝ⧇āϏāĻŦ āϤāĻĨā§āϝ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇ āϤāĻž āύāĻŋāĻŽā§āύāϰ⧂āĻĒ:

ā§§. āĻœā§‡āύ⧇āϟāĻŋāĻ• āωāĻĒāĻžāĻĻāĻžāύ

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϜāĻ¨ā§āϝ āĻāĻ•āϟāĻŋ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒā§āϰāĻŦāĻŖāϤāĻž āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ…āύ⧇āĻ• āϏāĻŽāϝāĻŧ āĻĒāϰāĻŋāĻŦāĻžāϰ⧇ āĻāĻ•āĻžāϧāĻŋāĻ• āϏāĻĻāĻ¸ā§āϝāĻĻ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻāχ āϏāĻŽāĻ¸ā§āϝāĻž āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧ, āϝāĻž āχāĻ™ā§āĻ—āĻŋāϤ āĻĻ⧇āϝāĻŧ āϝ⧇ āϜāĻŋāύāĻ—āϤ āĻ•āĻžāϰāĻŖ āĻāϟāĻŋāϰ āĻĒā§āϰāϧāĻžāύ āĻ‰ā§ŽāϏ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻ•āĻŋāϛ⧁ āĻŦāĻŋāĻļ⧇āώ āϧāϰāύ⧇āϰ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻŽāĻŋāωāĻŸā§‡āĻļāύ āĻŦāĻž āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āĻāχ āϏāĻŽāĻ¸ā§āϝāĻž āωāĻĻā§āĻ­ā§‚āϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

⧍. āχāĻŽāĻŋāωāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽā§‡āϰ āĻ—ā§‹āϞāĻŽāĻžāϞ

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻ‰ā§ŽāĻĒāĻ¤ā§āϤāĻŋ āĻ…āύ⧇āĻ• āϏāĻŽāϝāĻŧ āĻ…āĻŸā§‹āχāĻŽāĻŋāωāύ āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž āĻŦāĻž āχāĻŽāĻŋāωāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽā§‡āϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āϤāĻž āĻĨ⧇āϕ⧇ āĻšāϝāĻŧāĨ¤ āĻāϤ⧇, āĻļāϰ⧀āϰ⧇āϰ āύāĻŋāϜāĻ¸ā§āĻŦ āϕ⧋āώ⧇āϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ āφāĻ•ā§āϰāĻŽāĻŖ āϘāĻŸā§‡, āϝāĻž āϘāĻž āĻŦāĻž āĻ•ā§āώāϤ āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāχ āϧāϰāύ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻŽā§āĻ–āĻ—āĻšā§āĻŦāϰ⧇āϰ āĻŽāĻŋāωāϕ⧋āϏāĻž (āĻŽā§āϖ⧇āϰ āĻļā§āϞ⧇āĻˇā§āĻŽāĻž āĻ¸ā§āϤāϰ) āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

ā§Š. āĻ­āĻžāχāϰāĻžāϞ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ

āĻ•āĻŋāϛ⧁ āĻ—āĻŦ⧇āώāĻŖāĻžāϝāĻŧ āĻĻ⧇āĻ–āĻž āϗ⧇āϛ⧇ āϝ⧇, āĻ•āĻŋāϛ⧁ āĻ­āĻžāχāϰāĻžāϞ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻšāĻŋāωāĻŽā§āϝāĻžāύ āĻšā§‡āϰāĻĒāĻŋāϏ āĻ­āĻžāχāϰāĻžāϏ (Herpes simplex virus) āĻāĻŦāĻ‚ āĻāĻĒāĻ¸ā§āĻŸā§‡āχāύ-āĻŦāĻžāϰ āĻ­āĻžāχāϰāĻžāϏ (Epstein-Barr virus) āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ āϧāϰāύ⧇āϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻļāϰ⧀āϰ⧇āϰ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āĻĻ⧁āĻ°ā§āĻŦāϞ āĻ•āϰ⧇ āĻĻ⧇āϝāĻŧ, āϝāĻž āĻ•ā§āώāϤ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇āĨ¤

ā§Ē. āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ

āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ (stress) āĻāĻŦāĻ‚ āωāĻĻā§āĻŦ⧇āĻ— āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻ…āĻ¨ā§āϝāϤāĻŽ āĻ•āĻžāϰāĻŖ āĻšāĻŋāϏ⧇āĻŦ⧇ āϚāĻŋāĻšā§āύāĻŋāϤ āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇āĨ¤ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻļāϰ⧀āϰ⧇āϰ āχāĻŽāĻŋāωāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽāϕ⧇ āĻĻ⧁āĻ°ā§āĻŦāϞ āĻ•āϰ⧇ āĻĻ⧇āϝāĻŧ āĻāĻŦāĻ‚ āĻāϟāĻŋ āĻŽā§āĻ–āĻ—āĻšā§āĻŦāϰ⧇āϰ āĻļā§āϞ⧇āĻˇā§āĻŽāĻž āĻ¸ā§āϤāϰ⧇āϰ āĻ•ā§āώāϤ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

ā§Ģ. āĻ–āĻžāĻĻā§āϝ āĻ“ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ

āĻ•āĻŋāϛ⧁ āĻ–āĻžāĻŦāĻžāϰ āĻŦāĻž āωāĻĒāĻžāĻĻāĻžāύ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϝ⧇āĻŽāύ:

  • āϏāĻžāχāĻŸā§āϰāĻžāϏ āĻĢāϞ (āϞ⧇āĻŦ⧁, āĻ•āĻŽāϞāĻž)
  • āϟāĻŽā§‡āĻŸā§‹ āĻŦāĻž āĻŽāĻļāϞāĻžāĻĻāĻžāϰ āĻ–āĻžāĻŦāĻžāϰ
  • āϚāĻ•āϞ⧇āϟ āĻŦāĻž āĻ•ā§āϝāĻžāĻĢ⧇āχāύ āĻ•āĻŋāϛ⧁ āϞ⧋āϕ⧇āϰ āϜāĻ¨ā§āϝ āϏāĻŽāĻ¸ā§āϝāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
    āĻ…āĻ¨ā§āϝāĻĻāĻŋāϕ⧇, āĻ•āĻŋāϛ⧁ āϞ⧋āĻ• āĻ–āĻžāĻĻā§āϝ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋāϰ āĻ•āĻžāϰāϪ⧇ āĻāχ āϧāϰāύ⧇āϰ āφāϞāϏāĻžāϰ⧇ āϭ⧁āĻ—āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

ā§Ŧ. āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ⧇āϰ āϘāĻžāϟāϤāĻŋ

āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ B12, āĻĢā§‹āϞāĻŋāĻ• āĻ…ā§āϝāĻžāϏāĻŋāĻĄ, āĻāĻŦāĻ‚ āφāϝāĻŧāϰāύ āĻāϰ āϘāĻžāϟāϤāĻŋ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āωāĻĻā§āϰ⧇āĻ• āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāϏāĻŦ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ⧇āϰ āĻ…āĻ­āĻžāĻŦ āĻļāϰ⧀āϰ⧇āϰ āϕ⧋āώ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝāϕ⧇ āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇ āĻāĻŦāĻ‚ āϏ⧇āϗ⧁āϞāĻŋ āĻ•ā§āώāϤ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻŽā§āĻ–āĻ—āĻšā§āĻŦāϰ⧇āϰ āĻļā§āϞ⧇āĻˇā§āĻŽāĻž āĻ¸ā§āϤāϰ⧇āĨ¤

ā§­. āĻšāϰāĻŽā§‹āύāĻžāϞ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ

āĻŽāĻšāĻŋāϞāĻžāĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇, āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻž, āĻŽāĻžāϏāĻŋāĻ• āϚāĻ•ā§āϰ āĻŦāĻž āĻšāϰāĻŽā§‹āύāĻžāϞ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻšāĻ“āϝāĻŧāĻžāϰ āĻĒā§āϰāĻŦāĻŖāϤāĻž āĻŦ⧇āĻĄāĻŧ⧇ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāχ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύāϗ⧁āϞāĻŋāϰ āĻĢāϞ⧇ āĻļāϰ⧀āϰ⧇āϰ āχāĻŽāĻŋāωāύ āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āφāϞāϏāĻžāϰ āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇āĨ¤

ā§Ž. āĻŽā§āĻ–āĻ—āĻšā§āĻŦāϰ⧇ āφāϘāĻžāϤ āĻŦāĻž āĻ•ā§āώāϤāĻŋ

āĻŽā§āϖ⧇ āĻŦāĻž āĻĻāĻžāρāϤ⧇ āϕ⧋āύ⧋ āφāϘāĻžāϤ āĻŦāĻž āĻ•ā§āώāϤāĻŋ, āϝ⧇āĻŽāύ āĻĻāĻžāρāϤ⧇āϰ āĻŦā§āϰ⧇āϏ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻŦāĻž āĻ•āĻ āĻŋāύ āĻ–āĻžāĻŦāĻžāϰ āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āϏāĻŽāϝāĻŧ āĻĻāĻžāρāϤ⧇ āφāϘāĻžāϤ āϞāĻžāĻ—āĻž, āĻŽā§āϖ⧇āϰ āĻļā§āϞ⧇āĻˇā§āĻŽāĻž āĻ¸ā§āϤāϰāϕ⧇ āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āĻĒāϰ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϰ⧂āĻĒ āύāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

⧝. āϏāĻ‚āĻ•ā§āϰāĻžāĻŽāĻ• āϰ⧋āĻ—

āĻ•āĻŋāϛ⧁ āϏāĻ‚āĻ•ā§āϰāĻžāĻŽāĻ• āϰ⧋āĻ—āĻ“ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āωāĻĻāĻžāĻšāϰāĻŖāĻ¸ā§āĻŦāϰ⧂āĻĒ, āϏ⧋āϰāĻŋāϝāĻŧāĻžāϟāĻŋāĻ• āφāĻ°ā§āĻĨā§āϰāĻžāχāϟāĻŋāϏ, āĻ•ā§āϰ⧋āύāϏ āĻĄāĻŋāϜāĻŋāϜ āĻŦāĻž āϏāĻŋāĻ¸ā§āϟāĻŋāĻ• āĻĢāĻžāχāĻŦā§āϰ⧋āϏāĻŋāϏ āϝ⧇āĻšā§‡āϤ⧁ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻž āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻ•āϰ⧇, āϤāĻžāχ āĻāϰāĻž āĻŽā§āϖ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻāϗ⧁āϞ⧋ āĻ›āĻžāĻĄāĻŧāĻžāĻ“ āĻ•āĻŋāϛ⧁ āϞ⧋āϕ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ–āĻžāĻĻā§āϝ āĻŦāĻž āĻĒāϰāĻŋāĻŦ⧇āĻļāĻ—āϤ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύāĻ“ āĻāχ āϏāĻŽāĻ¸ā§āϝāĻž āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Symptomps:-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous ulcers) āĻšāϞ āĻŽā§āϖ⧇āϰ āĻ­āĻŋāϤāϰ⧇āϰ āϕ⧋āĻˇā§āĻ  āĻŦāĻž āĻ—āĻžāϞ, āϜāĻŋāĻ­, āϤāĻžāϞ⧁ āĻŦāĻž āĻ ā§‹āρāĻŸā§‡ āϛ⧋āϟ, āĻŦ⧇āĻĻāύāĻžāĻĻāĻžāϝāĻŧāĻ• āϘāĻž āϝāĻž āϏāĻžāϧāĻžāϰāĻŖāϤ āϏāĻžāĻĻāĻž āĻŦāĻž āĻšāϞ⧁āĻĻ āϰāϙ⧇āϰ āĻšāϝāĻŧ āĻāĻŦāĻ‚ āĻāϰ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϞāĻžāϞ āĻĻāĻžāĻ— āĻĨāĻžāϕ⧇āĨ¤ āĻāχ āφāϞāϏāĻžāϰāϗ⧁āϞāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ•āĻŋāϛ⧁āĻĻāĻŋāύ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āϏ⧇āϰ⧇ āϝāĻžāϝāĻŧ, āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻŽāĻžāĻā§‡ āĻŽāĻžāĻā§‡ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Davidson’s Principles and Practice of Medicine āĻ…āύ⧁āϏāĻžāϰ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϞāĻ•ā§āώāĻŖ āĻāĻŦāĻ‚ āωāĻĒāϏāĻ°ā§āĻ—āϗ⧁āϞāĻŋ āύāĻŋāĻŽā§āύāϰ⧂āĻĒ:

āϞāĻ•ā§āώāĻŖ:

  1. āĻŦā§āϝāĻĨāĻž āĻ“ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ:
    1. āϘāĻž āϏ⧃āĻˇā§āϟāĻŋ āĻšāĻ“āϝāĻŧāĻžāϰ āĻĒāϰ āĻŦā§āϝāĻĨāĻž āĻ…āύ⧁āĻ­ā§‚āϤ āĻšāϝāĻŧ, āϝāĻž āĻ•āĻĨāĻž āĻŦāϞāĻžāϰ āϏāĻŽāϝāĻŧ āĻŦāĻž āĻ–āĻžāĻŦāĻžāϰ āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āϏāĻŽāϝāĻŧ āφāϰāĻ“ āĻŦ⧇āĻĄāĻŧ⧇ āϝāĻžāϝāĻŧāĨ¤
  2. āĻŽā§āϖ⧇ āϘāĻž:
    1. āĻŽā§āϖ⧇āϰ āĻ­āĻŋāϤāϰ⧇ āϛ⧋āϟ, āϏāĻžāĻĻāĻž āĻŦāĻž āĻšāϞ⧁āĻĻ āĻŦāĻ°ā§āύ⧇āϰ āφāϞāϏāĻžāϰ āϝāĻž āϏāĻžāϧāĻžāϰāĻŖāϤ 2-8 āĻŽāĻŋāϞāĻŋāĻŽāĻŋāϟāĻžāϰ āĻŦā§āϝāĻžāϏ⧇āϰ āĻšāϝāĻŧāĨ¤
  3. āϞāĻžāϞ āϰāĻŋāĻ‚:
    1. āϘāĻžāϰ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϞāĻžāϞ āϰāĻ‚āϝāĻŧ⧇āϰ āĻŦ⧃āĻ¤ā§āϤ āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧāĨ¤
  4. āĻ—āϞāĻž āĻŦāĻž āĻŽā§āϖ⧇ āĻœā§āĻŦāĻžāϞāĻž:
    1. āĻ…āύ⧇āĻ• āϏāĻŽāϝāĻŧ āĻŽā§āϖ⧇ āĻœā§āĻŦāĻžāϞāĻž āĻ…āύ⧁āĻ­ā§‚āϤ āĻšāϝāĻŧ āĻāĻŦāĻ‚ āĻ—āϞāĻž āĻŦāĻž āĻŽā§āϖ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϝāĻŧāĨ¤

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous ulcers) āĻāϰ āϜāĻ¨ā§āϝ āĻ•āĻŋāϛ⧁ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āωāĻĒāϏāĻ°ā§āĻ—āĻ“ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻĻāĻŋāĻ“ āĻāϗ⧁āϞāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŽā§ŒāϞāĻŋāĻ• āωāĻĒāϏāĻ°ā§āĻ—āϗ⧁āϞāĻŋāϰ āϏāĻ™ā§āϗ⧇ āϝ⧁āĻ•ā§āϤ āĻšāϝāĻŧāĨ¤ āĻ•āĻŋāϛ⧁ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āωāĻĒāϏāĻ°ā§āĻ— āϝāĻž Davidson’s Principles and Practice of Medicine-āĻ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āĻšāϝāĻŧ⧇āϛ⧇, āϤāĻž āĻšāϞ⧋:

āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āωāĻĒāϏāĻ°ā§āĻ—āϏāĻŽā§‚āĻš:

  1. āĻœā§āĻŦāϰ (Fever):
    1. āĻ•āĻ–āύāĻ“ āĻ•āĻ–āύāĻ“, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āϝāĻĻāĻŋ āĻāϟāĻŋ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāϜāύāĻŋāϤ āĻ•āĻžāϰāϪ⧇ āĻšāϝāĻŧ, āĻļāϰ⧀āϰ⧇ āϏāĻžāĻŽāĻžāĻ¨ā§āϝ āĻœā§āĻŦāϰ āωāĻ āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āϏāĻŋāϰāĻŋāϜ āφāĻ•ā§āϰāĻŽāϪ⧇āϰ āϜāĻ¨ā§āϝ āύāϝāĻŧāĨ¤
  2. āϞāϏāĻŋāĻ•āĻž āĻ—ā§āϰāĻ¨ā§āĻĨāĻŋāϰ āĻ¸ā§āĻĢā§€āϤāĻŋ (Lymphadenopathy):
    1. āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ—āϞāĻžāϰ āĻŦāĻž āĻŽā§āϖ⧇āϰ āύāĻŋāĻ•āϟāĻŦāĻ°ā§āϤ⧀ āϞāϏāĻŋāĻ•āĻž āĻ—ā§āϰāĻ¨ā§āĻĨāĻŋ āĻ¸ā§āĻĢā§€āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āĻĒā§āϰāĻĻāĻžāĻšā§‡āϰ āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻžāĨ¤
  3. āĻļāĻ•ā§āϤāĻŋ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻž (Fatigue):
    1. āφāϞāϏāĻžāϰ āϖ⧁āĻŦāχ āĻŦā§āϝāĻĨāĻžāϝ⧁āĻ•ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻžāϰ āĻ•āĻžāϰāϪ⧇ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻ•ā§āϞāĻžāĻ¨ā§āϤāĻŋ āĻŦāĻž āĻļāĻ•ā§āϤāĻŋāϰ āĻ…āĻ­āĻžāĻŦ āĻ…āύ⧁āĻ­ā§‚āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  4. āĻ–āĻžāĻŦāĻžāϰ āϖ⧇āϤ⧇ āϏāĻŽāĻ¸ā§āϝāĻž (Difficulty Eating):
    1. āĻŽā§āϖ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ•ā§āώāϤ āĻĨāĻžāĻ•āĻžāϝāĻŧ āĻ–āĻžāĻŦāĻžāϰ āϖ⧇āϤ⧇ āĻ•āĻˇā§āϟ āĻšāϤ⧇ āĻĒāĻžāϰ⧇ āĻāĻŦāĻ‚ āĻŽā§āϖ⧇āϰ āφāϘāĻžāϤ⧇ āϰāĻ•ā§āϤāĻĒāĻžāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ—ā§āϰāĻšāϪ⧇ āĻŦāĻžāϧāĻž āĻĻ⧇āϝāĻŧāĨ¤
  5. āĻŽā§āϖ⧇āϰ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ (Mouth Discomfort):
    1. āĻŽā§āϖ⧇āϰ āĻ­āĻŋāϤāϰ⧇ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āĻŦāĻž āĻœā§āĻŦāĻžāϞāĻž āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇ āϝāĻž āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ–āĻžāĻŦāĻžāϰ āĻŦāĻž āĻĒāĻžāύ⧀āϝāĻŧ āĻĒāĻžāύ āĻ•āϰāĻžāϰ āϏāĻŽāϝāĻŧ āĻŦ⧃āĻĻā§āϧāĻŋ āĻĒāĻžāϝāĻŧāĨ¤

āωāĻ˛ā§āϞ⧇āĻ–āϝ⧋āĻ—ā§āϝ āĻŦāĻŋāώāϝāĻŧ:

āĻāϟāĻŋ āĻŽāύ⧇ āϰāĻžāĻ–āĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϝ⧇, āĻāϏāĻŦ āωāĻĒāϏāĻ°ā§āĻ— āϏāĻžāϧāĻžāϰāĻŖāϤ āϖ⧁āĻŦ āϤ⧀āĻŦā§āϰ āĻšāϝāĻŧ āύāĻž āĻāĻŦāĻ‚ āĻŦ⧇āĻļāĻŋāϰāĻ­āĻžāĻ— āϏāĻŽāϝāĻŧ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻāχ āϧāϰāύ⧇āϰ āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āϏāĻžāĻĨ⧇āχ āϘāĻž āϏ⧇āϰ⧇ āϝāĻžāϝāĻŧāĨ¤ āϤāĻŦ⧇, āϝāĻĻāĻŋ āωāĻĒāϏāĻ°ā§āĻ—āϗ⧁āϞāĻŋ āĻĻā§€āĻ°ā§āϘ āϏāĻŽāϝāĻŧ āϧāϰ⧇ āϚāϞāϤ⧇ āĻĨāĻžāϕ⧇ āĻŦāĻž āύāϤ⧁āύ āϏāĻŽāĻ¸ā§āϝāĻž āϏ⧃āĻˇā§āϟāĻŋ āĻšāϝāĻŧ, āϤāĻžāĻšāϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

Clinical Investigation Diagonosis:-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ (Aphthous ulcers) āϜāĻ¨ā§āϝ clinical investigation āĻŦāĻž āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āϏāĻ āĻŋāĻ• āύāĻŋāĻ°ā§āĻŖāϝāĻŧ āĻ•āϰāĻž āĻ…āĻ¤ā§āϝāĻ¨ā§āϤ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤ Davidson’s Principles and Practice of Medicine āĻ…āύ⧁āϝāĻžāϝāĻŧā§€, āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϜāĻ¨ā§āϝ āĻ•āĻŋāϛ⧁ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āωāĻĒāϏāĻ°ā§āϗ⧇āϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋāϤ⧇ āĻāĻŦāĻ‚ āϰ⧋āĻ—ā§€āϰ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋ āĻŦ⧁āĻā§‡ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

1. āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āχāϤāĻŋāĻšāĻžāϏ āĻ“ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž (Clinical History and Physical Examination):

  • āĻĒā§āϰāĻĨāĻŽāϤ, āϰ⧋āĻ—ā§€āϰ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āχāϤāĻŋāĻšāĻžāϏ āύ⧇āϝāĻŧāĻž āĻšāϝāĻŧ, āϝāĻžāϰ āĻŽāĻ§ā§āϝ⧇ āφāϛ⧇:
    • āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āχāϤāĻŋāĻšāĻžāϏ: āĻ–āĻžāĻĻā§āϝ, āĻŽāϞāĻŽ āĻŦāĻž āĻ…āĻ¨ā§āϝ āĻ•āĻŋāϛ⧁āϤ⧇ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻĨāĻžāĻ•āϞ⧇āĨ¤
    • āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ: āϕ⧋āύ āϧāϰāϪ⧇āϰ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻŦāĻž āωāĻĻā§āĻŦ⧇āϗ⧇āϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤
    • āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āϰ⧋āĻ—: āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ, āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ, āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āϰ⧋āϗ⧇āϰ āχāϤāĻŋāĻšāĻžāϏāĨ¤
  • āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āφāϞāϏāĻžāϰ⧇āϰ āφāĻ•āĻžāϰ, āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻāĻŦāĻ‚ āϤāĻžāĻĻ⧇āϰ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϕ⧋āύ⧋ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϞāĻžāϞ āĻ­āĻžāĻŦ āϰāϝāĻŧ⧇āϛ⧇ āĻ•āĻŋ āύāĻž āϤāĻž āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

2. āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻž (Blood Tests):

āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞāĻŋ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇ āϝāĻĻāĻŋ:

  • āĻšāĻŋāĻŽā§‹āĻ—ā§āϞ⧋āĻŦāĻŋāύ (Hemoglobin) āĻāĻŦāĻ‚ āĻšā§‡āĻŽāĻžāĻŸā§‹āĻ•ā§āϰāĻŋāϟ (Hematocrit):
    • āĻāϟāĻŋ āĻ…ā§āϝāĻžāύāĻŋāĻŽāĻŋāϝāĻŧāĻž āĻŦāĻž āϰāĻ•ā§āϤāĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻž āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāĻ•āĨ¤ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āϝāĻĻāĻŋ āϰāĻ•ā§āϤāĻ¸ā§āĻŦāĻ˛ā§āĻĒāϤāĻžāϰ āϏāĻžāĻĨ⧇ āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻšāϝāĻŧ, āϤāĻŦ⧇ āĻāϟāĻŋ āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧāĨ¤
  • C-reactive protein (CRP):
    • āĻāχ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āϰāĻĻāĻžāĻšā§‡āϰ āĻ¸ā§āϤāϰ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰ⧇, āϝāĻžāϤ⧇ āĻļāϰ⧀āϰ⧇ āϕ⧋āύ⧋ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āφāϛ⧇ āĻ•āĻŋāύāĻž āĻŦā§‹āĻāĻž āϝāĻžāϝāĻŧāĨ¤
  • āϏāĻžāĻ°ā§āĻŦāĻŋāĻ• āϏ⧇āϞ āϏāĻŋāĻĄāĻŋāĻŽā§‡āĻ¨ā§āĻŸā§‡āĻļāύ āϰ⧇āϟ (ESR):
    • āĻāϟāĻŋ āĻĒā§āϰāĻĻāĻžāĻšā§‡āϰ āĻĒāϰāĻŋāĻŽāĻžāĻĒ āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇, āϝāĻĻāĻŋ āĻļāϰ⧀āϰ⧇ āϕ⧋āύ⧋ āĻĒā§āϰāĻĻāĻžāĻš āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ ESR āĻŦ⧃āĻĻā§āϧāĻŋ āĻĒāĻžāĻŦ⧇āĨ¤
  • āϞāĻŋāĻ­āĻžāϰ āĻāĻŦāĻ‚ āĻ•āĻŋāĻĄāύāĻŋ āĻĢāĻžāĻ‚āĻļāύ āĻŸā§‡āĻ¸ā§āϟ:
    • āϝāĻĻāĻŋ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻāϕ⧇āĻŦāĻžāϰ⧇ āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻā§€ āĻŦāĻž āĻŽāĻžāϰāĻžāĻ¤ā§āĻŽāĻ• āφāĻ•āĻžāϰ āϧāĻžāϰāĻŖ āĻ•āϰ⧇, āϤāĻžāĻšāϞ⧇ āϞāĻŋāĻ­āĻžāϰ āĻŦāĻž āĻ•āĻŋāĻĄāύāĻŋāϰ āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻž āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

3. āĻŽāĻžāχāĻ•ā§āϰ⧋āĻŦāĻžāϝāĻŧā§‹āϞāϜāĻŋāĻ•āĻžāϞ āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞāĻŋ (Microbiological Tests):

  • āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϞ āĻ•āĻžāϞāϚāĻžāϰ (Bacterial Culture):
    • āϝāĻĻāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϏāĻ¨ā§āĻĻ⧇āĻš āĻ•āϰ⧇āύ āϝ⧇ āϕ⧋āύ⧋ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻŦāĻž āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻž āϰāϝāĻŧ⧇āϛ⧇, āϤāĻŦ⧇ āφāϞāϏāĻžāϰ⧇āϰ āĻ•ā§āώāϤ āĻĨ⧇āϕ⧇ āĻāĻ•āϟāĻŋ āύāĻŽā§āύāĻž āϏāĻ‚āĻ—ā§āϰāĻš āĻ•āϰ⧇ āĻ•āĻžāϞāϚāĻžāϰ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāϤ⧇ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻž āĻŦāĻž āĻ­āĻžāχāϰāĻžāϏ⧇āϰ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤
  • āĻ­āĻžāχāϰāĻžāϞ āĻ•āĻžāϞāϚāĻžāϰ (Viral Culture):
    • āĻ•āĻ–āύāĻ“ āĻ•āĻ–āύāĻ“, āĻšāĻŋāωāĻŽā§āϝāĻžāύ āĻšā§‡āϰāĻĒāĻŋāϏ āϏāĻŋāĻŽāĻĒā§āϞ⧇āĻ•ā§āϏ āĻ­āĻžāχāϰāĻžāϏ (HSV) āĻŦāĻž āϏāĻžāχāĻŸā§‹āĻŽā§‡āĻ—āĻžāϞ⧋ āĻ­āĻžāχāϰāĻžāϏ (CMV) āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻžāχ āĻāχ āĻĒāϰ⧀āĻ•ā§āώāĻžāϗ⧁āϞāĻŋ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

4. āĻāĻ¨ā§āϟāĻŋāĻŦāĻĄāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻž (Antibody Tests):

  • Herpes Simplex Virus (HSV) Antibody Test:
    • āĻāχ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĻā§āĻŦāĻžāϰāĻž āĻšā§‡āϰāĻĒāĻŋāϏ āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤ āϝāĻĻāĻŋ HSV āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āϏāĻ¨ā§āĻĻ⧇āĻš āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻāĻ¨ā§āϟāĻŋāĻŦāĻĄāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

5. āĻ¸ā§āϕ⧋āĻĒāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻž (Endoscopy):

  • āĻāĻ¨ā§āĻĄā§‹āĻ¸ā§āϕ⧋āĻĒāĻŋ (Oral Endoscopy):
    • āϝāĻĻāĻŋ āφāϞāϏāĻžāϰ āϖ⧁āĻŦ āϗ⧁āϰ⧁āϤāϰ āĻšāϝāĻŧ āĻŦāĻž āĻ•āĻŋāϛ⧁ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϗ⧁āϰ⧁āϤāϰ āϏāĻŽāĻ¸ā§āϝāĻž (āϝ⧇āĻŽāύ āϟāĻŋāωāĻŽāĻžāϰ āĻŦāĻž āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ) āϏāĻ¨ā§āĻĻ⧇āĻš āĻ•āϰāĻž āĻšāϝāĻŧ, āϤāĻŦ⧇ āĻāĻ¨ā§āĻĄā§‹āĻ¸ā§āϕ⧋āĻĒāĻŋāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻŽā§āϖ⧇āϰ āĻ­āĻŋāϤāϰ āφāϞāϏāĻžāϰ⧇āϰ āĻ…āĻŦāĻ¸ā§āĻĨāĻžāύ āĻĒāĻ°ā§āϝāĻžāϞ⧋āϚāύāĻž āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

6. āĻāϞāĻžāĻ°ā§āϜāĻŋ āĻĒāϰ⧀āĻ•ā§āώāĻž (Allergy Tests):

  • āĻ¸ā§āĻ•āĻŋāύ āĻĒā§āϰāĻŋāĻ• āĻŸā§‡āĻ¸ā§āϟ (Skin Prick Test):
    • āϝāĻĻāĻŋ āϕ⧋āύ⧋ āĻ–āĻžāĻĻā§āϝ āĻŦāĻž āωāĻĒāĻžāĻĻāĻžāύ⧇ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋāϰ āĻ•āĻžāϰāϪ⧇ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻ¸ā§āĻ•āĻŋāύ āĻĒā§āϰāĻŋāĻ• āĻŸā§‡āĻ¸ā§āϟ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āχāĻŽāĻŋāωāύ⧋āĻ—ā§āϞ⧋āĻŦ⧁āϞāĻŋāύ āχ (IgE) āĻŸā§‡āĻ¸ā§āϟ:
    • āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ–āĻžāĻĻā§āϝ āĻŦāĻž āĻĒāϰāĻŋāĻŦ⧇āĻļāĻ—āϤ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āϏāύāĻžāĻ•ā§āϤ āĻ•āϰāϤ⧇ āĻāχ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

7. āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻĒāϰ⧀āĻ•ā§āώāĻž (Other Tests):

  • āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āϜāĻ¨ā§āϝ āĻŦā§āϞāĻžāĻĄ āϏ⧁āĻ—āĻžāϰ āϞ⧇āϭ⧇āϞ (Blood Sugar Test):
    • āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ āĻĨāĻžāĻ•āϞ⧇, āĻāϟāĻŋ āĻŽā§āϖ⧇āϰ āφāϞāϏāĻžāϰ⧇āϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻžāχ āĻŦā§āϞāĻžāĻĄ āϏ⧁āĻ—āĻžāϰ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻ“ āĻŽāĻŋāύāĻžāϰ⧇āϞ āĻŸā§‡āĻ¸ā§āϟ (Vitamin and Mineral Tests):
    • āĻ•āĻŋāϛ⧁ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇, āĻŦāĻŋāĻļ⧇āώāϤ āϝāĻžāĻĻ⧇āϰ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻž āĻŽāĻŋāύāĻžāϰ⧇āϞ āĻ…āĻ­āĻžāĻŦ āĻĨāĻžāϕ⧇, āϤāĻžāĻĻ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻžāχ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ⧧⧍, āĻĢāϞ⧇āϟ āĻŦāĻž āφāϝāĻŧāϰāύ āĻāϰ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āωāĻĒāϏāĻ‚āĻšāĻžāϰ:

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϜāĻ¨ā§āϝ āϏāĻžāϧāĻžāϰāĻŖāϤ āϕ⧋āύ āϗ⧁āϰ⧁āϤāϰ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϝāĻŧ āύāĻž, āϤāĻŦ⧇ āϝāĻ–āύ āĻāϟāĻŋ āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻšāϝāĻŧ⧇ āϝāĻžāϝāĻŧ āĻŦāĻž āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āϘāĻŸā§‡, āϤāĻ–āύ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āϝāĻĻāĻŋ āĻāϟāĻŋ āĻ…āĻ¨ā§āϝ āϕ⧋āύ⧋ āĻļāĻžāϰ⧀āϰāĻŋāĻ• āϏāĻŽāĻ¸ā§āϝāĻž āĻŦāĻž āϰ⧋āϗ⧇āϰ āϏāĻžāĻĨ⧇ āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇āĨ¤ āϏāĻŦ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āϞāĻŋāύāĻŋāĻ•ā§āϝāĻžāϞ āĻ…āĻŦāĻ¸ā§āĻĨāĻž āĻāĻŦāĻ‚ āφāϞāϏāĻžāϰ⧇āϰ āϞāĻ•ā§āώāĻŖ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

Treatment Management:-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ (Aphthous ulcers) āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž āĻāĻŦāĻ‚ āĻ“āώ⧁āϧ āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āϤāĻĨā§āϝ Davidson’s Principles and Practice of Medicine āĻ…āύ⧁āϏāĻžāϰ⧇ āĻāĻ–āĻžāύ⧇ āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰāĻž āĻšāϞāĨ¤ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽ, āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋ āĻāĻŦāĻ‚ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āωāĻĒāϰ āĻŽāύ⧋āύāĻŋāĻŦ⧇āĻļ āĻ•āϰ⧇āĨ¤

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž (Treatment Management)

  1. āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽāĻ•āĻžāϰ⧀ (Pain Relief):
    1. āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽ āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ• āĻŽāϞāĻŽ āĻŦāĻž āϗ⧇āϞāĻž āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤ āĻāϰ āĻŽāĻ§ā§āϝ⧇ āϏāĻŦāĻšā§‡āϝāĻŧ⧇ āĻĒā§āϰāϚāϞāĻŋāϤ āĻšāϞ āĻŦ⧇āύāĻœā§‹āϕ⧇āχāύ āĻāĻŦāĻ‚ āϞāĻŋāĻĄā§‹āϕ⧇āχāύāĨ¤
  2. āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋ (Anti-inflammatory Treatment):
    1. āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āĻ•ā§āϰāĻŋāĻŽ āĻŦāĻž āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ (āϝ⧇āĻŽāύ āĻšāĻžāχāĻĄā§āϰ⧋āĻ•āϰāϟāĻŋāϏ⧋āύ āĻŦāĻž āĻŦ⧇āϤāĻžāĻŽā§‡āĻĨāĻžāϏ⧋āύ) āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤
    1. āĻ…āϰāĻžāϞ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ (āϝ⧇āĻŽāύ āĻĒā§āϰ⧇āĻĄāύāĻŋāϏ⧋āϞ⧋āύ) āϏāĻžāϧāĻžāϰāĻŖāϤ āϗ⧁āϰ⧁āϤāϰ āϕ⧇āϏ⧇āϰ āϜāĻ¨ā§āϝ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧāĨ¤
  3. āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ• āĻāĻŦāĻ‚ āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āϰ⧋āϧ (Antibiotics and Viral Infection Control):
    1. āϝāĻĻāĻŋ āϏ⧇āϕ⧇āĻ¨ā§āĻĄāĻžāϰāĻŋ āχāύāĻĢ⧇āĻ•āĻļāύ āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ• āϝ⧇āĻŽāύ āφāĻŽā§‹āĻ•ā§āϏāĻŋāϏāĻŋāϞāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇, āĻāϟāĻŋ āĻļ⧁āϧ⧁ āϤāĻ–āύāχ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āωāϚāĻŋāϤ āϝāĻ–āύ āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĨāĻžāϕ⧇āĨ¤
  4. āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻāĻŦāĻ‚ āĻŽāĻŋāύāĻžāϰ⧇āϞ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ (Vitamin and Mineral Supplements):
    1. āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ⧧⧍ āĻāĻŦāĻ‚ āĻĢāϞ⧇āϟ āĻ…āĻ­āĻžāĻŦ⧇āϰ āĻ•āĻžāϰāϪ⧇ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻžāχ āĻāχ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύāϗ⧁āϞāĻŋāϰ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ (āϝ⧇āĻŽāύ āϏāĻžāϝāĻŧāĻžāύ⧋-āϕ⧋āĻŦāĻžāϞāĻžāĻŽāĻŋāύ) āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  5. āĻ…ā§āϝāĻžāĻ¸ā§āĻŸā§āϰāĻŋāĻ‚āĻœā§‡āĻ¨ā§āϟ (Astringents):
    1. āĻ•āĻŋāϛ⧁ āϰ⧋āĻ—ā§€āϕ⧇ āĻ…ā§āϝāĻžāϞ⧁āĻŽāĻŋāύāĻŋāϝāĻŧāĻžāĻŽ āĻ…ā§āϝāĻžāϏ⧇āĻŸā§‡āϟ (Aluminum acetate) āĻŦāĻž āĻ…ā§āϝāĻžāϭ⧇āĻ¨ā§āĻĄāĻžāϏ (Avendas) āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āφāϞāϏāĻžāϰ⧇āϰ āϚāĻžāϰāĻĒāĻžāĻļ⧇ āϜāĻŽā§‡ āĻĨāĻžāĻ•āĻž āϤāϰāϞ āĻļā§‹āώāĻŖ āĻ•āϰāϤ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇āĨ¤

āĻ“āώ⧁āϧ⧇āϰ āĻĢāĻžāĻ°ā§āĻŽāĻžāϕ⧋āϞāϜāĻŋ (Pharmacology of Medications)

  1. āĻŦ⧇āύāĻœā§‹āϕ⧇āχāύ (Benzocaine) – Local Anesthetic:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ• āϝāĻž āφāϞāϏāĻžāϰ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻšāĻ“āϝāĻŧāĻž āĻŦā§āϝāĻĨāĻž āĻ•āĻŽāĻžāϤ⧇ āϏāĻšāĻžāϝāĻŧāĻ•āĨ¤ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŽāϞāĻŽ āĻŦāĻž āϗ⧇āϞāĻž āφāĻ•āĻžāϰ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻ¸ā§āύāĻžāϝāĻŧ⧁āϰ āωāĻ¤ā§āϤ⧇āϜāύāĻž āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•āϰ⧇ āĻāĻŦāĻ‚ āĻŦā§āϝāĻĨāĻž āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻ•āĻŽāĻŋāϝāĻŧ⧇ āĻĻ⧇āϝāĻŧāĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Dentogel, OragelāĨ¤
  2. āϞāĻŋāĻĄā§‹āϕ⧇āχāύ (Lidocaine) – Local Anesthetic:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ•, āϝāĻž āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽ āĻ•āϰāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻ¸ā§āύāĻžāϝāĻŧ⧁ āϤāĻ¨ā§āϤ⧁āϤ⧇ āĻĒā§āϰāĻ­āĻžāĻŦ āĻĢ⧇āϞ⧇ āĻāĻŦāĻ‚ āĻŦā§āϝāĻĨāĻž āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇āĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Xylocaine, LidodermāĨ¤
  3. āĻĒā§āϰ⧇āĻĄāύāĻŋāϏ⧋āϞ⧋āύ (Prednisolone) – Corticosteroid:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āϝāĻž āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāϤ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤ āĻāϟāĻŋ āϗ⧁āϰ⧁āϤāϰ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧāĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āĻļāϰ⧀āϰ⧇ āϕ⧋āĻ°ā§āϟāĻŋāϕ⧋āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āĻšāϰāĻŽā§‹āύ⧇āϰ āĻ•āĻžāϜ āĻ…āύ⧁āĻ•āϰāĻŖ āĻ•āϰ⧇āĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Prednisolone, OrasoneāĨ¤
  4. āĻŦ⧇āϤāĻžāĻŽā§‡āĻĨāĻžāϏ⧋āύ (Betamethasone) – Corticosteroid:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻāϟāĻŋ āφāϰ⧇āĻ•āϟāĻŋ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āϝāĻž āϤ⧀āĻŦā§āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāϤ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŽāϞāĻŽ āĻŦāĻž āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ āφāĻ•āĻžāϰ⧇ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧāĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāϝāĻŧ āĻāĻŦāĻ‚ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āωāĻĒāĻļāĻŽ āĻ•āϰ⧇āĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Betnovate, BetadermāĨ¤
  5. āφāĻŽā§‹āĻ•ā§āϏāĻŋāϏāĻŋāϞāĻŋāύ (Amoxicillin) – Antibiotic:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āϝāĻĻāĻŋ āφāϞāϏāĻžāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāϪ⧇āϰ āĻ•āĻžāϰāϪ⧇ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϝāĻŧ, āϤāĻŦ⧇ āφāĻŽā§‹āĻ•ā§āϏāĻŋāϏāĻŋāϞāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϰ āϏ⧇āϞ āĻ“āϝāĻŧāĻžāϞ āϤ⧈āϰāĻŋ āĻšāϤ⧇ āĻŦāĻžāϧāĻž āĻĻ⧇āϝāĻŧ, āϝāĻžāϰ āĻĢāϞ⧇ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻšāϝāĻŧāĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Amoxil, AmoxāĨ¤
  6. āϏāĻžāϝāĻŧāĻžāύ⧋-āϕ⧋āĻŦāĻžāϞāĻžāĻŽāĻŋāύ (Cyanocobalamin) – Vitamin B12 Supplement:
    1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ⧧⧍-āĻāϰ āĻ…āĻ­āĻžāĻŦ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻžāχ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ āĻĻ⧇āĻ“āϝāĻŧāĻž āĻšāϝāĻŧāĨ¤
    1. āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻāϟāĻŋ āϞ⧋āĻšāĻŋāϤ āϰāĻ•ā§āϤāĻ•āĻŖāĻŋāĻ•āĻž āĻ‰ā§ŽāĻĒāĻžāĻĻāύ⧇ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻ•āϰ⧇ āĻāĻŦāĻ‚ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϤāĻ¨ā§āĻ¤ā§āϰ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ•āĻžāĻ°ā§āϝāĻ•āĻžāϰāĻŋāϤāĻž āĻŦāϜāĻžāϝāĻŧ āϰāĻžāϖ⧇āĨ¤
    1. āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“āϝāĻŧāĻž āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ āύāĻžāĻŽ: Cobadex CZS, NeurobionāĨ¤

āύāĻŋāĻ°ā§āĻĻ⧇āĻļāύāĻž (Precautions) āĻ“ āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž (Side Effects):

  1. āĻŦ⧇āύāĻœā§‹āϕ⧇āχāύ:
    1. āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻĻā§€āĻ°ā§āϘāĻ•āĻžāϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞāϤāĻž āĻŦāĻž āĻ¸ā§āύāĻžāϝāĻŧ⧁ āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
    1. āϏāϤāĻ°ā§āĻ•āϤāĻž: āϛ⧋āϟ āĻļāĻŋāĻļ⧁āĻĻ⧇āϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āĻĒā§‚āĻ°ā§āĻŦ⧇ āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āύāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤
  2. āĻĒā§āϰ⧇āĻĄāύāĻŋāϏ⧋āϞ⧋āύ:
    1. āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻ“āϜāύ āĻŦ⧃āĻĻā§āϧāĻŋ, āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ, āĻŦāĻž āχāĻŽāĻŋāωāύ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āĻĻ⧁āĻ°ā§āĻŦāϞ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
    1. āϏāϤāĻ°ā§āĻ•āϤāĻž: āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄā§‡āϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ⧇ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

āωāĻĒāϏāĻ‚āĻšāĻžāϰ:

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ•āϰāĻžāϰ āϏāĻŽāϝāĻŧ āĻ“āώ⧁āϧ⧇āϰ āϏāĻ āĻŋāĻ• āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ…āĻ¤ā§āϝāĻ¨ā§āϤ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤ āωāĻĒāϰ⧇āϰ āωāĻ˛ā§āϞ⧇āĻ–āĻŋāϤ āĻ“āώ⧁āϧāϗ⧁āϞāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āφāϞāϏāĻžāϰ⧇āϰ āϞāĻ•ā§āώāĻŖ āωāĻĒāĻļāĻŽ āĻāĻŦāĻ‚ āĻĻā§āϰ⧁āϤ āϏ⧇āϰ⧇ āĻ“āĻ āĻžāϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧāĨ¤ āϤāĻŦ⧇, āϝāĻĻāĻŋ āφāϞāϏāĻžāϰ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āϘāĻŸā§‡ āĻŦāĻž āϗ⧁āϰ⧁āϤāϰ āĻšāϝāĻŧ, āϤāĻžāĻšāϞ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ⧇ āωāĻĒāϝ⧁āĻ•ā§āϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

āĻāĻ–āĻžāύ⧇ āĻāĻ•āϟāĻŋ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻāϰ āϜāĻ¨ā§āϝ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž (āĻĒā§āϰāĻŋāϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ) āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰāĻž āĻšāϞ, Davidson’s Principles and Practice of Medicine āĻ…āύ⧁āϝāĻžāϝāĻŧā§€, āϝ⧇āϟāĻŋ āĻāĻ•āϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž āĻšāĻŦ⧇āĨ¤


āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ: āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous Ulcer)

āϰ⧋āĻ—ā§€ āύāĻžāĻŽ: [āϰ⧋āĻ—ā§€āϰ āύāĻžāĻŽ]
āϤāĻžāϰāĻŋāĻ–: [āϤāĻžāϰāĻŋāĻ–]
āĻĄāĻžāĻ•ā§āϤāĻžāϰ: [āĻĄāĻžāĻ•ā§āϤāĻžāϰ āύāĻžāĻŽ]
āωāĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ: [āϰ⧋āĻ—ā§€āϰ āĻŦāϝāĻŧāϏ/āϞāĻŋāĻ™ā§āĻ—]
āĻ āĻŋāĻ•āĻžāύāĻž: [āĻĄāĻžāĻ•ā§āϤāĻžāϰ āĻ āĻŋāĻ•āĻžāύāĻž]


1. āĻŦ⧇āĻžā§āĻœā§‹āϕ⧇āχāύ (Benzocaine) – āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ• (Topical Analgesic)

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āφāϞāϏāĻžāϰ⧇āϰ āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽā§‡āϰ āϜāĻ¨ā§āϝāĨ¤
  • āĻĄā§‹āϜ: āĻĻāĻŋāύ ā§Š-ā§Ē āĻŦāĻžāϰ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ¸ā§āĻĨāĻžāύ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰ⧁āύāĨ¤
  • āĻ…āĻŦāĻ¸ā§āĻĨāĻž: āĻŽāϞāĻŽ āφāĻ•āĻžāϰ⧇āĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ…āĻžā§āϚāϞ⧇ āĻŽāϞāĻŽ āϞāĻžāĻ—āĻŋāϝāĻŧ⧇ ⧍-ā§Š āĻŽāĻŋāύāĻŋāϟ āĻ…āĻĒ⧇āĻ•ā§āώāĻž āĻ•āϰ⧁āύ, āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āφāϗ⧇ āĻāĻŦāĻ‚ āĻĒāϰ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰ⧁āύāĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āϖ⧁āĻŦ āĻĻā§€āĻ°ā§āϘāĻ•āĻžāϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĨ⧇āϕ⧇ āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞāϤāĻž āĻŦāĻž āĻ¤ā§āĻŦāϕ⧇ āĻœā§āĻŦāĻžāϞāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

2. āĻĒā§āϰ⧇āĻĄāύāĻŋāϏ⧋āϞ⧋āύ (Prednisolone) – āĻ…āϰāĻžāϞ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ (Oral Steroid)

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āϗ⧁āϰ⧁āϤāϰ āφāϞāϏāĻžāϰ āĻāĻŦāĻ‚ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝāĨ¤
  • āĻĄā§‹āϜ: 5mg āĻĒā§āϰāϤāĻŋāĻĻāĻŋāύ ā§§āϟāĻŋ āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ, ā§Ģ-ā§­ āĻĻāĻŋāύāĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻĒāϰ⧇ āϏ⧇āĻŦāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϰ āĻ•ā§āώāϤāĻŋ, āĻ“āϜāύ āĻŦāĻžāĻĄāĻŧāĻžāύ⧋, āĻšāϜāĻŽ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

3. āĻŦ⧇āϤāĻžāĻŽā§‡āĻĨāĻžāϏ⧋āύ (Betamethasone) – āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ (Topical Steroid)

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āφāϞāϏāĻžāϰ⧇āϰ āĻĒā§āϰāĻĻāĻžāĻš āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝāĨ¤
  • āĻĄā§‹āϜ: āĻĻāĻŋāύ⧇ ⧍ āĻŦāĻžāϰ affected āĻ¸ā§āĻĨāĻžāύ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰ⧁āύ (āĻ…āĻĨāĻŦāĻž āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻ…āύ⧁āϏāĻžāϰ⧇)āĨ¤
  • āĻ…āĻŦāĻ¸ā§āĻĨāĻž: āĻŽāϞāĻŽ āĻŦāĻž āĻœā§‡āϞ āφāĻ•āĻžāϰ⧇āĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻ¤ā§āĻŦāϕ⧇ āĻœā§āĻŦāĻžāϞāĻž āĻŦāĻž āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāϞ⧇ āĻ¤ā§āĻŦāϕ⧇āϰ āĻĒāĻžāϤāϞāĻž āĻšāĻ“āϝāĻŧāĻžāĨ¤
  • āϏāϤāĻ°ā§āĻ•āϤāĻž: āϖ⧁āĻŦ āĻŦ⧇āĻļāĻŋ āĻĻāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ āύāĻž āĻ•āϰāĻžāĨ¤

4. āϏāĻžāϝāĻŧāĻžāύ⧋–āϕ⧋āĻŦāĻžāϞāĻžāĻŽāĻŋāύ (Cyanocobalamin) – āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ B12 Supplement

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ B12 āĻāϰ āĻ…āĻ­āĻžāĻŦ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻšāϞ⧇āĨ¤
  • āĻĄā§‹āϜ: ā§§āϟāĻŋ āχāύāĻœā§‡āĻ•āĻļāύ (ā§§ā§Ļā§Ļā§Ļ mcg) āĻĒā§āϰāϤāĻŋ āĻŽāĻžāϏ⧇ āĻāĻ•āĻŦāĻžāϰāĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āĻĄāĻžāĻ•ā§āϤāĻžāϰ āĻŦāĻž trained āύāĻžāĻ°ā§āϏ āĻĻā§āĻŦāĻžāϰāĻž āχāύāĻœā§‡āĻ•āĻļāύ āĻĒā§āϰāϝāĻŧā§‹āĻ—āĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āϖ⧁āĻŦāχ āĻŦāĻŋāϰāϞ, āϤāĻŦ⧇ āĻ•āĻŋāϛ⧁ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋāĻ• āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

5. āĻ…ā§āϝāĻžāĻŽā§‹āĻ•ā§āϏāĻŋāϏāĻŋāϞāĻŋāύ (Amoxicillin) – āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ• (Antibiotic)

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻšāϞ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤
  • āĻĄā§‹āϜ: ā§Ģā§Ļā§Ļmg, āĻĻāĻŋāύ⧇ ā§Š āĻŦāĻžāϰ, ā§­ āĻĻāĻŋāύāĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻĒāϰ⧇ āϏ⧇āĻŦāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻšāĻžāϞāĻ•āĻž āĻĒ⧇āĻŸā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž, āĻĄāĻžāϝāĻŧāϰāĻŋāϝāĻŧāĻžāĨ¤

6. āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ (Mouthwash)

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āĻ…āϰāĻžāϞ āĻšāĻžāχāϜāĻŋāύ āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āϤ⧇ āĻāĻŦāĻ‚ āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽ āĻ•āϰāϤ⧇āĨ¤
  • āĻĄā§‹āϜ: āĻĻāĻŋāύ⧇ ⧍-ā§Š āĻŦāĻžāϰ āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰ⧁āύ, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻĒāϰ⧇āĨ¤
  • āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄ: Hexident Mouthwash āĻŦāĻž Chlorhexidine MouthwashāĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻŽā§āϖ⧇āϰ āĻ¸ā§āĻŦāĻžāĻĻ āĻŦāĻĻāϞāĻžāύ⧋, āĻĻā§€āĻ°ā§āϘ āϏāĻŽāϝāĻŧ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻŽā§āϖ⧇āϰ āĻļ⧁āĻˇā§āĻ•āϤāĻžāĨ¤

āĻŽāĻ¨ā§āϤāĻŦā§āϝ:

  • āϝāĻĻāĻŋ āφāϞāϏāĻžāϰāϗ⧁āϞāĻŋ āφāϰāĻ“ āϗ⧁āϰ⧁āϤāϰ āĻŦāĻž āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻšāϝāĻŧ⧇ āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻĒ⧁āύāϰāĻžāϝāĻŧ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āύāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻ”āώāϧ⧇āϰ āϏāĻžāĻĨ⧇ āϏāĻžāĻĨ⧇ āϰ⧋āĻ—ā§€āϰ āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻ•āĻŽāĻžāύ⧋āϰ āϜāĻ¨ā§āϝ āϏāĻ āĻŋāĻ• āĻŦāĻŋāĻļā§āϰāĻžāĻŽ āĻāĻŦāĻ‚ āĻĄāĻžāϝāĻŧ⧇āϟ āĻŽā§‡āύ⧇ āϚāϞāĻž āϜāϰ⧁āϰāĻŋāĨ¤
  • āϕ⧋āĻ˛ā§āĻĄ āϏ⧋āĻ°ā§āϏ āĻŦāĻž āĻŽāϏāϞāĻžāϝ⧁āĻ•ā§āϤ āĻ–āĻžāĻŦāĻžāϰ āĻĨ⧇āϕ⧇ āĻĻā§‚āϰ⧇ āĻĨāĻžāĻ•āϤ⧇ āĻšāĻŦ⧇, āĻ•āĻžāϰāĻŖ āĻāϗ⧁āϞāĻŋ āφāϞāϏāĻžāϰāϕ⧇ āφāϰāĻ“ āĻŦā§āϝāĻĨāĻžāϝ⧋āĻ—ā§āϝ āĻ•āϰ⧇ āϤ⧁āϞāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Clinical Case :-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous Ulcer), āϝāĻžāϕ⧇ āϏāĻžāϧāĻžāϰāĻŖāĻ­āĻžāĻŦ⧇ āĻŽā§āϖ⧇āϰ āϘāĻž āĻŦāĻž āĻŽāĻžāωāĻĨ āφāϞāϏāĻžāϰ āĻŦāϞāĻž āĻšāϝāĻŧ, āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖ, āĻ…-āϏāĻ‚āĻ•ā§āϰāĻžāĻŽāĻ• āĻ“ āĻŦā§āϝāĻĨāĻžāϝ⧁āĻ•ā§āϤ āϏāĻŽāĻ¸ā§āϝāĻžāĨ¤ āĻāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āϜāĻŋāĻšā§āĻŦāĻž, āĻ ā§‹āρāĻŸā§‡āϰ āĻ­āĻŋāϤāϰ⧇āϰ āĻ…āĻ‚āĻļ, āĻ—āĻžāϞ āĻŦāĻž āĻŽāĻžāĻĄāĻŧāĻŋāϤ⧇ āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧāĨ¤

—

đŸ§Ē āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϧāϰāύ:

ā§§. āĻŽāĻžāχāύāϰ āφāϞāϏāĻžāϰ (Minor Aphthous Ulcer):

āϏāĻŦāĻšā§‡āϝāĻŧ⧇ āϏāĻžāϧāĻžāϰāĻŖ āϧāϰāύ⧇āϰāĨ¤

āφāĻ•āĻžāϰ⧇ āϛ⧋āϟ (ā§Š-ā§§ā§Ļ āĻŽāĻŋāĻŽāĻŋ)āĨ¤

āύāĻŋāĻœā§‡ āύāĻŋāĻœā§‡ ā§­-ā§§ā§Ē āĻĻāĻŋāύ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āϏ⧇āϰ⧇ āϝāĻžāϝāĻŧāĨ¤

⧍. āĻŽā§‡āϜāϰ āφāϞāϏāĻžāϰ (Major Aphthous Ulcer):

āĻŦāĻĄāĻŧ, āĻ—āĻ­ā§€āϰ āĻ“ āĻŦ⧇āĻļāĻŋ āĻŦā§āϝāĻĨāĻžāϝ⧁āĻ•ā§āϤāĨ¤

ā§§ā§Ļ āĻŽāĻŋāĻŽāĻŋāϰ āĻŦ⧇āĻļāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϏ⧇āϰ⧇ āϝ⧇āϤ⧇ āĻ•āϝāĻŧ⧇āĻ• āϏāĻĒā§āϤāĻžāĻšāĻ“ āϞāĻžāĻ—āϤ⧇ āĻĒāĻžāϰ⧇ āĻāĻŦāĻ‚ āĻĻāĻžāĻ— āϰ⧇āϖ⧇ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

ā§Š. āĻšāĻžāϰāĻĒ⧇āϟāĻŋāĻĢāĻ°ā§āĻŽ āφāϞāϏāĻžāϰ (Herpetiform Ulcer):

āĻ…āϏāĻ‚āĻ–ā§āϝ āĻ•ā§āώ⧁āĻĻā§āϰ āĻ•ā§āώāϤ āĻāĻ•āϏāĻžāĻĨ⧇ āĻšāϝāĻŧ (ā§§ā§Ļā§ĻāϟāĻŋāϰ āĻŽāϤ⧋āĻ“ āĻšāϤ⧇ āĻĒāĻžāϰ⧇)āĨ¤

āφāĻ•āĻžāϰ⧇ āϛ⧋āϟ āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻāĻ•āĻ¤ā§āϰ⧇ āĻŦ⧇āĻļ āĻ•āĻˇā§āϟāĻĻāĻžāϝāĻŧāĻ•āĨ¤

—

📌 āϞāĻ•ā§āώāĻŖāϏāĻŽā§‚āĻš:

āĻŽā§āϖ⧇āϰ āϭ⧇āϤāϰ⧇ āĻ—ā§‹āϞ āĻŦāĻž āĻĄāĻŋāĻŽā§āĻŦāĻžāĻ•ā§ƒāϤāĻŋāϰ āϏāĻžāĻĻāĻž āĻŦāĻž āĻšāϞāĻĻ⧇ āϕ⧇āĻ¨ā§āĻĻā§āϰāĻŦāĻŋāĻļāĻŋāĻˇā§āϟ āϞāĻžāϞ āĻŦāĻ°ā§āĻĄāĻžāϰāϝ⧁āĻ•ā§āϤ āϘāĻž

āĻŦā§āϝāĻĨāĻž āĻ“ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹āĻĄāĻŧāĻž

āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āϏāĻŽāϝāĻŧ āĻŦāĻž āĻ•āĻĨāĻž āĻŦāϞāĻžāϰ āϏāĻŽāϝāĻŧ āĻ…āϏ⧁āĻŦāĻŋāϧāĻž

āĻ•āĻ–āύāĻ“ āĻšāĻžāϞāĻ•āĻž āĻœā§āĻŦāϰ āĻ“ āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž

—

đŸŽ¯ āĻ•āĻžāϰāĻŖāϏāĻŽā§‚āĻš:

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϏāĻ āĻŋāĻ• āĻ•āĻžāϰāĻŖ āϜāĻžāύāĻž āϝāĻžāϝāĻŧāύāĻŋ, āϤāĻŦ⧇ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖāϗ⧁āϞ⧋ āĻšāϞ:

āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻŦāĻž āĻŸā§‡āύāĻļāύ

āĻŽā§āϖ⧇ āφāϘāĻžāϤ (āĻĻāĻžāρāϤ āĻŦā§āϰāĻžāĻļ⧇āϰ āϏāĻŽāϝāĻŧ āĻ•āĻžāϟāĻž, āĻ ā§‹āρāĻŸā§‡ āĻ•āĻžāĻŽāĻĄāĻŧ āĻĻ⧇āĻ“āϝāĻŧāĻž)

āĻĒ⧁āĻˇā§āϟāĻŋāϰ āĻ…āĻ­āĻžāĻŦ (Vitamin B12, āĻĢā§‹āϞāĻŋāĻ• āĻ…ā§āϝāĻžāϏāĻŋāĻĄ, āφāϝāĻŧāϰāύ)

āĻšāϰāĻŽā§‹āύāϜāύāĻŋāϤ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ (āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āύāĻžāϰ⧀āĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇)

āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒā§āϰāĻŦāĻŖāϤāĻž (āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ• āχāϤāĻŋāĻšāĻžāϏ)

āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻŦāĻž āĻĢ⧁āĻĄ āϏ⧇āĻ¨ā§āϏāĻŋāϟāĻŋāĻ­āĻŋāϟāĻŋ (āϚāĻ•āϞ⧇āϟ, āϟāĻŽā§‡āĻŸā§‹, āĻŽāϏāϞāĻžāϝ⧁āĻ•ā§āϤ āĻ–āĻžāĻŦāĻžāϰ)

āĻ•āĻŋāϛ⧁ āĻ“āώ⧁āϧ (NSAIDs, āĻŦāĻŋāϟāĻž-āĻŦā§āϞāĻ•āĻžāϰ, āϕ⧇āĻŽā§‹āĻĨ⧇āϰāĻžāĻĒāĻŋ)

āϰ⧋āĻ— (Crohn’s disease, Celiac disease, HIV āχāĻ¤ā§āϝāĻžāĻĻāĻŋ)

—

đŸ§Ŧ āĻĄāĻžāϝāĻŧāĻžāĻ—āύ⧋āϏāĻŋāϏ:

āϏāĻžāϧāĻžāϰāĻŖāϤ āωāĻĒāϏāĻ°ā§āĻ— āĻĻ⧇āϖ⧇āχ āϚāĻŋāĻšā§āύāĻŋāϤ āĻ•āϰāĻž āϝāĻžāϝāĻŧāĨ¤ āϤāĻŦ⧇ āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻā§€ āĻŦāĻž āϗ⧁āϰ⧁āϤāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻŦāĻž āĻŦāĻžāϝāĻŧā§‹āĻĒāϏāĻŋ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤

—

💊 āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž:

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž (Treatment)

✅ āϏāĻžāϧāĻžāϰāĻŖ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž:

1. āĻŽā§āϖ⧇ āϞāĻžāĻ—āĻžāύ⧋āϰ āĻ“āώ⧁āϧ:

Mucopain gel / Bonjela gel

Hexigel (chlorhexidine mouthwash)

Candid mouth paint (āϝāĻĻāĻŋ āĻ›āĻ¤ā§āϰāĻžāĻ•āϜāύāĻŋāϤ āĻšāϝāĻŧ)

2. āĻŦā§āϝāĻĨāĻž āĻ•āĻŽāĻžāϤ⧇:

Paracetamol āĻŦāĻž Ibuprofen

Topical anesthetic gel

3. āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻ“ āĻŽāĻŋāύāĻžāϰ⧇āϞ:

Becosule, Neurobion Forte, āĻŦāĻž B-complex āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ

Iron + Folic acid + Vitamin C

4. āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ:

āĻ•ā§āϞ⧋āϰāĻšā§‡āĻ•ā§āϏāĻŋāĻĄāĻŋāύ (antiseptic)

āϞāĻŦāĻŖ āĻĒāĻžāύāĻŋ āĻĻāĻŋāϝāĻŧ⧇ āĻ—āĻžāĻ°ā§āĻ—āϞ

🏡 āϘāϰ⧋āϝāĻŧāĻž āĻĒā§āϰāϤāĻŋāĻ•āĻžāϰ (Home Remedies)

1. āϞāĻŦāĻŖ āĻĒāĻžāύāĻŋ āĻŦāĻž āĻŦ⧇āĻ•āĻŋāĻ‚ āϏ⧋āĻĄāĻž āĻĻāĻŋāϝāĻŧ⧇ āϕ⧁āϞāĻŋ – āĻœā§€āĻŦāĻžāϪ⧁ āĻ•āĻŽāĻžāϤ⧇ āϏāĻšāĻžāϝāĻŧāĻ•

2. āύāĻžāϰāϕ⧇āϞ āϤ⧇āϞ – āϘāĻžāϝāĻŧ⧇ āϞāĻžāĻ—āĻžāϞ⧇ āĻŦā§āϝāĻĨāĻž āĻ“ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻ•āĻŽā§‡

3. āϤ⧁āϞāϏ⧀ āĻĒāĻžāϤāĻž āϚāĻŋāĻŦāĻžāύ⧋ – āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϞ āϗ⧁āĻŖ āφāϛ⧇

4. āĻŽāϧ⧁ – āĻ•ā§āώāϤ āĻļ⧁āĻ•āĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇

5. āĻ āĻžāĻ¨ā§āĻĄāĻž āĻĻ⧁āϧ āĻŦāĻž āĻĻāχ āĻ–āĻžāĻ“āϝāĻŧāĻž – āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹āĻĄāĻŧāĻž āĻ•āĻŽāĻžāϝāĻŧ

6. āĻāϞ⧋āϭ⧇āϰāĻž āĻœā§‡āϞ – āĻ āĻžāĻŖā§āĻĄāĻž āĻ“ āωāĻĒāĻļāĻŽā§‡ āĻ•āĻžāĻ°ā§āϝāĻ•āϰ

âš ī¸ āĻ•āĻ–āύ āĻĄāĻžāĻ•ā§āϤāĻžāϰ āĻĻ⧇āĻ–āĻžāύ⧋ āϜāϰ⧁āϰāĻŋ?

āϝāĻĻāĻŋ āϘāĻž ā§­â€“ā§§ā§Ļ āĻĻāĻŋāύ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āύāĻž āĻļ⧁āĻ•āĻžāϝāĻŧ

āϝāĻĻāĻŋ āϘāĻž āφāĻŦāĻžāϰ āĻŦāĻžāϰāĻŦāĻžāϰ āĻĢāĻŋāϰ⧇ āφāϏ⧇

āϝāĻĻāĻŋ āϘāĻžāϝāĻŧ⧇āϰ āϏāĻžāĻĨ⧇ āĻœā§āĻŦāϰ, āĻ—āϞāĻž āĻŦā§āϝāĻĨāĻž āĻŦāĻž āĻļāϰ⧀āϰ āĻĻ⧁āĻ°ā§āĻŦāϞ āϞāĻžāϗ⧇

āϝāĻĻāĻŋ āϘāĻž āĻŦāĻĄāĻŧ āĻāĻŦāĻ‚ āĻ…āύ⧇āĻ•āϗ⧁āϞ⧋ āĻšāϝāĻŧ

āĻ–āĻžāĻŦāĻžāϰ āϖ⧇āϤ⧇ āĻāĻ•āĻĻāĻŽ āĻ•āĻˇā§āϟ āĻšāϝāĻŧ

📌 āϟāĻŋāĻĒāϏ:

āϖ⧁āĻŦ āĻāĻžāϞ, āϟāĻ•, āĻŦāĻž āĻ—āϰāĻŽ āĻ–āĻžāĻŦāĻžāϰ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞ⧁āύ

āĻŦ⧇āĻļāĻŋ āĻĒāĻžāύāĻŋ āĻĒāĻžāύ āĻ•āϰ⧁āύ

āĻŽā§āĻ– āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āϰāĻžāϖ⧁āύ

āĻ¸ā§āĻŸā§āϰ⧇āϏ āĻ•āĻŽāĻžāύ⧋āϰ āĻšā§‡āĻˇā§āϟāĻž āĻ•āϰ⧁āύāĨ¤

🟡 āϏāĻžāϧāĻžāϰāĻŖ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž (āĻšāĻžāϞāĻ•āĻž):

āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ: Chlorhexidine gluconate mouthwash

āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ• āĻœā§‡āϞ: Benzocaine, Lidocaine

āύ⧁āύ-āĻ—āϰāĻŽ āĻĒāĻžāύāĻŋāϰ āĻ—āĻžāĻ°ā§āĻ—āϞ

🔴 āϗ⧁āϰ⧁āϤāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇:

āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āĻœā§‡āϞ āĻŦāĻž āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ (Triamcinolone acetonide)

āχāĻŽāĻŋāωāύ-āĻŽāĻĄā§āϞ⧇āϟāϰ: āĻĨā§āϝāĻžāϞāĻŋāĻĄā§‹āĻŽāĻžāχāĻĄ āĻŦāĻž āĻĄā§āϝāĻžāĻĒāϏ⧋āύ (āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ⧇)

āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ: Vitamin B12, āĻĢā§‹āϞāĻŋāĻ• āĻ…ā§āϝāĻžāϏāĻŋāĻĄ, āφāϝāĻŧāϰāύ

—

✅ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇ āϝāĻž āĻ•āϰāĻŦ⧇āύ:

āĻŽā§āϖ⧇āϰ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ-āĻĒāϰāĻŋāĻšā§āĻ›āĻ¨ā§āύāϤāĻž āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āĻž

āϚāĻžāĻĒāĻŽā§āĻ•ā§āϤ āĻĨāĻžāĻ•āĻž āĻ“ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϘ⧁āĻŽ

āĻŽā§āϖ⧇ āφāϘāĻžāϤ āĻāĻĄāĻŧāĻžāύ⧋

āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻ…āύ⧁āϝāĻžāϝāĻŧā§€ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ āύ⧇āĻ“āϝāĻŧāĻž

āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻŦāĻž āϏ⧇āĻ¨ā§āϏāĻŋāϟāĻŋāĻ­ āĻ–āĻžāĻŦāĻžāϰ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞāĻž

—

âš ī¸ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻ•āĻ–āύ āύ⧇āĻŦ⧇āύ:

āϘāĻž ā§Š āϏāĻĒā§āϤāĻžāĻšā§‡āĻ“ āϏāĻžāϰ⧇ āύāĻž

āϘāĻž āĻŦāĻžāϰāĻŦāĻžāϰ āĻšāϝāĻŧ

āĻ–āĻžāĻ“āϝāĻŧāĻžāϝāĻŧ āĻŦāĻž āĻ•āĻĨāĻž āĻŦāϞāĻžāϝāĻŧ āĻŦāĻžāϧāĻž āĻĻ⧇āϝāĻŧ

āĻœā§āĻŦāϰ, āĻ•ā§āϞāĻžāĻ¨ā§āϤāĻŋ, āĻ“āϜāύ āĻ•āĻŽā§‡ āϝāĻžāĻ“āϝāĻŧāĻž āĻĻ⧇āĻ–āĻž āĻĻ⧇āϝāĻŧ


āĻĄāĻžāĻ•ā§āϤāĻžāϰ āϏāĻžāχāύ:
[āĻĄāĻžāĻ•ā§āϤāĻžāϰ āύāĻžāĻŽ]
āĻŦāĻŋāĻļ⧇āώāĻœā§āĻž
[āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āϕ⧇āĻ¨ā§āĻĻā§āϰ⧇āϰ āύāĻžāĻŽ]

Preventation:-

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ (Aphthous ulcers) āϏāĻžāϧāĻžāϰāĻŖāϤ āĻ…āĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āĻāĻŦāĻ‚ āĻŽā§ƒāĻĻ⧁ āĻĒā§āϰāĻ•ā§ƒāϤāĻŋāϰ āĻšāϝāĻŧ, āϤāĻŦ⧇ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Davidson’s Principles and Practice of Medicine āĻ…āύ⧁āϝāĻžāϝāĻŧā§€, āĻāχ āϰ⧋āϗ⧇āϰ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϜāĻ¨ā§āϝ āĻŦ⧇āĻļ āĻ•āĻŋāϛ⧁ āωāĻĒāĻžāϝāĻŧ āϰāϝāĻŧ⧇āϛ⧇ āϝāĻž āϰ⧋āĻ—ā§€āĻĻ⧇āϰ āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤ āĻāĻ–āĻžāύ⧇ āĻ•āϝāĻŧ⧇āĻ•āϟāĻŋ āĻĒā§āϰāϧāĻžāύ āωāĻĒāĻžāϝāĻŧ āϤ⧁āϞ⧇ āϧāϰāĻž āĻšāϞ⧋:

ā§§. āĻ–āĻžāĻĻā§āϝāĻžāĻ­ā§āϝāĻžāϏ⧇āϰ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ (Dietary Modifications)

  • āϤ⧀āĻ•ā§āĻˇā§āĻŖ āĻŦāĻž āĻŽāϏāϞāĻžāϝ⧁āĻ•ā§āϤ āĻ–āĻžāĻŦāĻžāϰ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞāĻž: āĻ…āϰāĻžāϞ āĻ•ā§āϝāĻžāĻ­āĻŋāϟāĻŋāϰ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϤ⧇ āĻ…āĻ¸ā§āĻŦāĻ¸ā§āϤāĻŋ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻŽāϏāϞāĻžāϝ⧁āĻ•ā§āϤ āĻ–āĻžāĻŦāĻžāϰ āĻŦāĻž āϤ⧀āĻ•ā§āĻˇā§āĻŖ āĻĒāĻŖā§āϝ āϝ⧇āĻŽāύ āϤāĻŋāϤāĻž āĻĢāϞ, āϟāĻŽā§‡āĻŸā§‹ āχāĻ¤ā§āϝāĻžāĻĻāĻŋ āĻĨ⧇āϕ⧇ āĻŦāĻŋāϰāϤ āĻĨāĻžāĻ•āϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āϏāĻš āĻ–āĻžāĻŦāĻžāϰ: āĻ•āĻŋāϛ⧁ āĻ–āĻžāĻĻā§āϝ āωāĻĒāĻžāĻĻāĻžāύ āϝ⧇āĻŽāύ āĻĻ⧁āϧ, āĻŽāĻŋāĻˇā§āϟāĻŋ, āĻ…āĻĨāĻŦāĻž āĻ•āĻŋāϛ⧁ āĻļāĻžāĻ•āϏāĻŦāϜāĻŋ (āϝ⧇āĻŽāύ āϟāĻŽā§‡āĻŸā§‹, āφāϞ⧁) āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāχ āϧāϰāύ⧇āϰ āĻ–āĻžāĻŦāĻžāϰ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞāĻž āωāϚāĻŋāϤāĨ¤
  • āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻ“ āĻŽāĻŋāύāĻžāϰ⧇āϞ⧇āϰ āϏāĻ āĻŋāĻ• āĻŽāĻžāĻ¤ā§āϰāĻž: āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻŋ⧧⧍, āĻĢāϞ⧇āϟ, āĻāĻŦāĻ‚ āφāϝāĻŧāϰāύ āĻāϰ āĻ…āĻ­āĻžāĻŦ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϏ⧁āϤāϰāĻžāĻ‚ āϏ⧁āώāĻŽ āĻ–āĻžāĻŦāĻžāϰ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰāĻž āĻāĻŦāĻ‚ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ āύ⧇āĻ“āϝāĻŧāĻž āωāĻĒāĻ•āĻžāϰ⧀āĨ¤

⧍. āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻ•āĻŽāĻžāύ⧋ (Stress Management)

  • āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻŦāĻž āωāĻĻā§āĻŦ⧇āĻ— āĻ•āĻŽāĻžāύ⧋: āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻāĻŦāĻ‚ āωāĻĻā§āĻŦ⧇āĻ— āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻāĻ• āĻ…āĻ¨ā§āϝāϤāĻŽ āĻ•āĻžāϰāĻŖāĨ¤ āϝ⧋āĻ—āĻŦā§āϝāĻžāϝāĻŧāĻžāĻŽ, āĻŽā§‡āĻĄāĻŋāĻŸā§‡āĻļāύ āĻŦāĻž āĻļāĻŋāĻĨāĻŋāϞāĻ•āϰāĻŖ āĻ•ā§ŒāĻļāϞāϗ⧁āϞāĻŋ āĻāχ āϚāĻžāĻĒ āĻ•āĻŽāĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻŦāĻŋāĻļā§āϰāĻžāĻŽ: āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āϘ⧁āĻŽ āĻāĻŦāĻ‚ āĻŦāĻŋāĻļā§āϰāĻžāĻŽ āĻŽāύ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰ āϜāĻ¨ā§āϝ āϖ⧁āĻŦāχ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻāĻŦāĻ‚ āĻāϟāĻŋ āϰ⧋āĻ— āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

ā§Š. āĻ­āĻžāϞ⧋ āĻŽā§āϖ⧇āϰ āĻšāĻžāχāϜāĻŋāύ (Good Oral Hygiene)

  • āĻŽā§āĻ– āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āϰāĻžāĻ–āĻž: āĻĻāĻŋāύ⧇ āĻ…āĻ¨ā§āϤāϤ āĻĻ⧁āϟāĻŋ āĻŦāĻžāϰ āĻŦā§āϰāĻžāĻļ āĻ•āϰāĻž āĻāĻŦāĻ‚ āĻŽā§āĻ– āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āϰāĻžāĻ–āϤ⧇ āϏāĻ āĻŋāĻ• āĻšāĻžāχāϜāĻŋāύ āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āĻžāĨ¤ āĻāϰ āĻĢāϞ⧇ āĻœā§€āĻŦāĻžāϪ⧁ āĻŦāĻž āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻž āĻŦ⧃āĻĻā§āϧāĻŋ āĻĒāĻžāĻŦ⧇ āύāĻž, āϝāĻž āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ āĻŦā§āϝāĻŦāĻšāĻžāϰ: āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻŽāĻžāωāĻĨāĻ“āϝāĻŧāĻžāĻļ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āĻāĻŦāĻ‚ āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻŦā§āϰāĻžāĻļ āĻ•āϰāĻž (āĻŽā§ƒāĻĻ⧁ āĻŦā§āϰāĻžāĻļ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž) āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

ā§Ē. āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻĒā§āϰāϤāĻŋāĻ•āĻžāϰ (Allergy Management)

  • āĻ–āĻžāĻĻā§āϝ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āϚāĻŋāĻšā§āύāĻŋāϤ āĻ•āϰāĻž: āĻ•āĻŋāϛ⧁ āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻĒā§āϰāϤāĻŋ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇, āϝāĻž āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ–āĻžāĻĻā§āϝ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻĨāĻžāĻ•āϞ⧇ āϏ⧇āϗ⧁āϞāĻŋ āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞāĻž āωāϚāĻŋāϤāĨ¤
  • āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ⧇ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻŸā§‡āĻ¸ā§āϟ: āĻ–āĻžāĻĻā§āϝ āĻŦāĻž āĻĒāϰāĻŋāĻŦ⧇āĻļāĻ—āϤ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋāϰ āϜāĻ¨ā§āϝ āĻ¸ā§āĻ•āĻŋāύ āĻŸā§‡āĻ¸ā§āϟ āĻŦāĻž āĻŦā§āϞāĻžāĻĄ āĻŸā§‡āĻ¸ā§āϟ āĻ•āϰāĻžāύ⧋ āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

ā§Ģ. āĻšāϰāĻŽā§‹āύāĻžāϞ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāĻŖ (Hormonal Control)

  • āĻŽāĻžāϏāĻŋāϕ⧇āϰ āφāϗ⧇ āĻŦāĻž āĻ—āĻ°ā§āĻ­āĻžāĻŦāĻ¸ā§āĻĨāĻžāϝāĻŧ āĻšāϰāĻŽā§‹āύ⧇āϰ āĻĒā§āϰāĻ­āĻžāĻŦ: āĻ…āύ⧇āĻ• āϏāĻŽāϝāĻŧ, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻŽāĻšāĻŋāϞāĻžāĻĻ⧇āϰ āĻŽāĻ§ā§āϝ⧇, āĻšāϰāĻŽā§‹āύāĻžāϞ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇āϰ āĻ•āĻžāϰāϪ⧇ āφāϞāϏāĻžāϰ āĻĻ⧇āĻ–āĻž āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻāχ āϏāĻŽāϝāĻŧ⧇ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝāĻ•āϰ āĻĄāĻžāϝāĻŧ⧇āϟ āĻāĻŦāĻ‚ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āĻŦāĻŋāĻļā§āϰāĻžāĻŽ āϰāĻžāĻ–āĻž āωāϚāĻŋāϤāĨ¤

ā§Ŧ. āĻ­āĻžāχāϰāĻžāϏ āĻāĻŦāĻ‚ āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻž āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĨ⧇āϕ⧇ āϏ⧁āϰāĻ•ā§āώāĻž (Prevention of Infection)

  • āĻšā§‡āϰāĻĒāĻŋāϏ āϏāĻŋāĻŽāĻĒā§āϞ⧇āĻ•ā§āϏ āĻ­āĻžāχāϰāĻžāϏ (HSV) āĻĒā§āϰāϤāĻŋāϰ⧋āϧ: āĻšā§‡āϰāĻĒāĻŋāϏ āĻ­āĻžāχāϰāĻžāϏ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇ āĻ¸ā§āϝāĻžāύāĻŋāϟāĻžāϰāĻŋ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž āĻāĻŦāĻ‚ āĻ­āĻžāχāϰāĻžāϞ āχāύāĻĢ⧇āĻ•āĻļāύ āĻĨ⧇āϕ⧇ āϏ⧁āϰāĻ•ā§āώāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤
  • āĻŦā§āϝāĻžāĻ•āĻŸā§‡āϰāĻŋāϝāĻŧāĻžāϰ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ: āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻŽā§āϖ⧇āϰ āĻĒāϰāĻŋāĻšā§āĻ›āĻ¨ā§āύāϤāĻž āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āĻž āĻāĻŦāĻ‚ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϜāĻ¨ā§āϝ āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧ āĻĒāĻĻāĻ•ā§āώ⧇āĻĒ āύ⧇āĻ“āϝāĻŧāĻž āωāϚāĻŋāϤāĨ¤

ā§­. āϟāĻžāύāĻž āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻĢāϞ⧋āφāĻĒ (Regular Health Check-ups)

  • āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž: āϝāĻĻāĻŋ āφāϞāϏāĻžāϰ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āĻšāϝāĻŧ, āϤāĻŦ⧇ āĻĄāĻžāĻ•ā§āϤāĻžāϰ⧀ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻžāύ⧋ āωāϚāĻŋāϤāĨ¤ āĻ•āĻŋāϛ⧁ āϏāĻŽāϝāĻŧ⧇ āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžāϝāĻŧā§€ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϝ⧇āĻŽāύ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āĻŦāĻž āĻŽāĻŋāύāĻžāϰ⧇āϞ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āĻŸā§‡āĻļāύāĨ¤
  • āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ āĻĒāϰ⧀āĻ•ā§āώāĻž: āϝ⧇āĻšā§‡āϤ⧁ āĻĄāĻžāϝāĻŧāĻžāĻŦ⧇āϟāĻŋāϏ⧇āϰ āϰ⧋āĻ—ā§€āϰ āĻŽāĻ§ā§āϝ⧇ āφāϞāϏāĻžāϰ āϏ⧃āĻˇā§āϟāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇, āϤāĻžāĻĻ⧇āϰ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻŦā§āϞāĻžāĻĄ āϏ⧁āĻ—āĻžāϰ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

ā§Ž. āϏāĻ āĻŋāĻ• āĻ”āώāϧ āĻŦā§āϝāĻŦāĻšāĻžāϰ (Appropriate Medication Use)

  • āĻĒā§āϰāϤāĻŋāϰ⧋āϧāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž: āϝāĻĻāĻŋ āϰ⧋āĻ—ā§€āϰ āĻĒā§‚āĻ°ā§āĻŦ⧇ āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻĄāĻžāĻ•ā§āϤāĻžāϰ āωāĻĒāϝ⧁āĻ•ā§āϤ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ¸ā§āĻŸā§‡āϰāϝāĻŧ⧇āĻĄ āĻ•ā§āϰāĻŋāĻŽ āĻŦāĻž āϗ⧇āϞāĻž āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤
  • āĻĒā§āϰāϤāĻŋāϰ⧋āϧāĻ• āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ• āĻŦā§āϝāĻŦāĻšāĻžāϰ: āϝāĻĻāĻŋ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖāϜāύāĻŋāϤ āĻ•āĻžāϰāĻŖ āĻĨāĻžāϕ⧇, āϤāĻŦ⧇ āĻ…ā§āϝāĻžāĻ¨ā§āϟāĻŋāĻŦāĻžāϝāĻŧā§‹āϟāĻŋāĻ• āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āωāĻĒāϏāĻ‚āĻšāĻžāϰ

āĻ…ā§āϝāĻžāĻĢāĻĨāĻžāϏ āφāϞāϏāĻžāϰ⧇āϰ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ⧇āϰ āϜāĻ¨ā§āϝ āĻ–āĻžāĻĻā§āϝāĻžāĻ­ā§āϝāĻžāϏ, āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ āĻ•āĻŽāĻžāύ⧋, āϏāĻ āĻŋāĻ• āĻŽā§ŒāĻ–āĻŋāĻ• āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻŦāϜāĻžāϝāĻŧ āϰāĻžāĻ–āĻž āĻāĻŦāĻ‚ āĻ…ā§āϝāĻžāϞāĻžāĻ°ā§āϜāĻŋ āĻ“ āĻ­āĻžāχāϰāĻžāϏ āϏāĻ‚āĻ•ā§āϰāĻŽāĻŖ āĻĒā§āϰāϤāĻŋāϰ⧋āϧ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤ āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϞ⧇āĻ“, āϏāĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āϝāĻ¤ā§āύ āύāĻŋāϞ⧇ āĻāĻŦāĻ‚ āωāĻĒāϰ⧇āϰ āϏāϤāĻ°ā§āĻ•āϤāĻžāϗ⧁āϞāĻŋ āĻ…āύ⧁āϏāϰāĻŖ āĻ•āϰāϞ⧇ āĻāϰ āĻĒ⧁āύāϰāĻžāĻŦ⧃āĻ¤ā§āϤāĻŋ āĻ•āĻŽāĻžāύ⧋ āϏāĻŽā§āĻ­āĻŦāĨ¤

Clinical Case:-

āĻ•āĻžāϰ⧋ āĻŽā§āϖ⧇ āĻĒā§āϰāĻžāϝāĻŧāχ āϛ⧋āϟ āϘāĻž āĻāϰ āĻŽāϤ⧋ āĻĻ⧇āĻ–āĻž āϝāĻžāϝāĻŧ āϏāĻžāĻĻāĻž āϛ⧋āϟ āϘāĻž, āĻŦāĻž āϞāĻžāϞ āĻĢā§‹āĻ¸ā§āĻ•āĻžāϰ āĻŽāϤ⧋ āĻŦ⧇āϰ āĻšāϝāĻŧ āϝāĻžāϰ āύāĻžāĻŽ đ˜ŧđ™Ĩ𝙝𝙩𝙝𝙤đ™Ē𝙨 đ™Ē𝙡𝙘𝙚𝙧𝙨 *

(Buccul mucosa Common site Of Apthous Ulcer*)Non Keratinized mucosa* āϤ⧇ āĻšāϝāĻŧ!!āĻœā§āĻŦāϰāĻ ā§‹āϏāĻžāϰ āĻŽāϤ āĻ ā§‹āρāĻŸā§‡āϰ āωāĻĒāϰ⧇,āĻŦāĻžāĻšāĻŋāϰ⧇ āĻšāϝāĻŧ āύāĻž..

āϛ⧋āĻŸā§āϟ āĻĨ⧇āϕ⧇ āĻŦ⧃āĻĻā§āϧ āĻŦāϝāĻŧāϏ āĻ…āĻŦāϧāĻŋ āϏāĻŽāĻ¸ā§āϝāĻžāϟāĻŋ āĻ•āĻŽ āĻŦ⧇āĻļāĻŋ āϏāĻ•āϞāϕ⧇āχ āĻ­ā§‹āĻ—āĻžāϝāĻŧāĨ¤āĻāχ āϏāĻŽāĻ¸ā§āϝāĻžāϝāĻŧ āĻ­ā§‹āϗ⧇āύāύāĻŋ āĻāĻŽāύ āĻŽāĻžāύ⧁āώ āĻ•āĻŽāχ āφāϛ⧇!!

āϞāĻ•ā§āώāύ āϗ⧁āϞ⧋ āĻšāϞ⧋ :–

â€ĸ āĻœā§āĻŦāĻžāϞāĻž āĻĒā§‹āĻĄāĻŧāĻžāĻ“ āĻŦā§āϝāĻžāĻĨāĻž

â€ĸ āϖ⧇āϤ⧇ āϗ⧇āϞ⧇ āĻœā§āĻŦāĻžāϞāĻž āĻŦ⧇āĻļāĻŋ āĻšāϝāĻŧ

â€ĸ āĻ…āĻ˛ā§āĻĒ āĻĢā§‹āϞāĻž ,āϘāĻž

đ˜ŧđ™Ĩ𝙝𝙩𝙝𝙤đ™Ē𝙨 Ulcer āĻāϰ āĻāϕ⧇āĻŦāĻžāϰ⧇ āϏāĻ āĻŋāĻ• āϕ⧋āύ⧋ āĻ•āĻžāϰāĻŖ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤āϤāĻŦ⧇ āĻ•āĻŋāϛ⧁ āĻ•āĻŋāϛ⧁ Aggravating factor āĻāϰ āϜāĻ¨ā§āϝ āĻšāϤ⧇ āĻĒāĻžāϰ⧇ āϝ⧇āĻŽāύ_________

āφāϘāĻžāϤ⧇āϰ āĻ•āĻžāϰāϪ⧇ āĻšāϤ⧇ āĻĒāĻžāϰ⧇

Stress,āϰāĻžāϤ āϜāĻžāĻ—āĻž

āĻŽā§‡āϝāĻŧ⧇āĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ During menstuation **most common

Immune suppressed āĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇

Hormonal Imbalances

Treatment

āĻĒā§āϰāĻĨāĻŽāϤ āĻāχāϟāĻž āĻšāϞ⧋ self Limiting ,So āύāĻŋāĻœā§‡ āύāĻŋāĻœā§‡āχ āϏ⧇āϰ⧇ āϝāĻžāϝāĻŧ ā§­-ā§§ā§Ē āĻĻāĻŋāύ āĻāϰ āĻŽāĻ§ā§āϝ⧇â€Ļ..āϤāĻŦ⧇ āĻ…āύ⧇āϕ⧇ āĻŽā§āϖ⧇ āϕ⧋āύ⧋ āϘāĻž āĻŽāĻžāύ⧇āχ Microral āĻœā§‡āϞ use āĻ•āϰ⧇āύ!!

– Aphthous Ulcer āĻāϰ āϜāĻ¨ā§āϝ Micoral gel āύāϝāĻŧ

So Mx should be..

Triamcinolone Oral paste(Best option)****

āĻŦāĻžāϜāĻžāϰ⧇ 𝙏𝙧𝙞ađ™Ąđ™¤đ™Ŗ 𝙤𝙧𝙖𝙡 đ™Ĩ𝙖𝙨𝙩𝙚 āύāĻžāĻŽā§‡ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧâ€Ļ

Oral Paste 1:-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Indications of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Cenolon Dental Paste USP, 0.1% is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma.

Pharmacology of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Like other topical corticosteroids, triamcinolone acetonide has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.

Dosage & Administration of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Press a small dab (about 1/4 inch) to the lesion until a thin film develops. A larger quantity may be required for coverage of some lesions. For optimal results use only enough to coat the lesion with a thin film. Do not rub in. Attempting to spread this preparation may result in a granular, gritty sensation and cause it to crumble. After application, however, a smooth, slippery film develops. The preparation should be applied at bedtime to permit steroid contact with the lesion throughout the night. Depending on the severity of symptoms, it may be necessary to apply the preparation two or three times a day, preferably after meals. If significant repair or regeneration has not occurred in seven days, further investigation is advisable.

Contraindications of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Triamcinolone acetonide dental paste is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat.

Side Effects of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa.

Pregnancy & Lactation of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Pregnancy Category C. Triamcinolone acetonide has been shown to induce teratogenic effects in several species. It is not known whether oral application of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Caution should be exercised when corticosteroid- containing dental pastes are prescribed for a nursing woman.

Precautions & Warnings of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Cenolon dental paste may cause local adverse reactions. If irritation develops, Cenolon dental paste should be discontinued and appropriate therapy instituted. Allergic contact sensitization with corticosteroids is usually diagnosed by observing failure to heal rather than noting a clinical exacerbation as with most topical products not containing corticosteroids. Such an observation should be corroborated with appropriate diagnostic patch testing.

If concomitant mucosal infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Cenolon dental paste should be discontinued until the infection has been adequately controlled. If significant regeneration or repair of oral tissues has not occurred in seven days, additional investigation into the etiology of the oral lesion is advised.

Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, glucosuria, and other adverse effects known to occur with parenterally-administered steroid preparations; therefore, it may be advisable to periodically evaluate patients on prolonged therapy with corticosteroid-containing dental pastes for evidence of HPA axis suppression. If HPA axis suppression is noted, an attempt should be made to withdraw the drug or to reduce the frequency of application. Recovery of HPA axis function is generally prompt and complete upon discontinuation of therapy.

Use in Special Populations

Pediatric Use: The safety and efficacy of Cenolon dental paste in children is unknown. Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing’s Syndrome than mature patients because of a larger skin surface area to body weight ratio. Administration of corticosteroid-containing dental pastes to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.

Geriatric Use: Clinical studies of Cenolon dental paste did not include sufficient numbers of subjects age 65 and older to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.

Therapeutic Class of Oral Paste :-Cenolon 0.1% 10gm tube (AS A Triamcinolone Acetonide AS A Corticosteroid, Glucocorticoids).

Corticosteroid, Glucocorticoids

OR

  • đ˜ŧđ™Ĩ𝙨𝙤𝙡 𝙤𝙧𝙖𝙡 đ™Ĩ𝙖𝙨𝙩𝙚 also Useful**
  • Oral Paste 2:-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).
  •  
  • Indications of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Apsol is indicated for the treatment of aphthous ulcers.

  • Pharmacology of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

The mechanism of action by which Amlexanox accelerates healing of aphthous ulcers is unknown. In vitro studies have demonstrated Amlexanox to be a potent inhibitor of the formation and release of inflammatory mediators (histamine and leukotrienes) from mast cells, neutrophils and mononuclear cells. Given orally to animals, Amlexanox has demonstrated anti-allergic and anti-inflammatory activities and has been shown to suppress both immediate and delayed-type hypersensitivity reactions. The relevance of these activities of Amlexanox to its effects on aphthous ulcers has not been established. After a single oral application of 100 mg of paste (5 mg Amlexanox), maximal serum levels are observed at 2.4 hours. Most of the systemic absorption of Amlexanox is via the gastrointestinal tract and the amount absorbed directly through the active ulcer is not a significant portion of the applied dose. The half-life for elimination was 3.5 +/- 1.1 hours in healthy individuals.

  • Dosage & Administration of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).
  • Apply the paste as soon as possible after noticing the symptoms of an aphthous ulcer. Continue to use the paste four times daily, preferably following oral hygiene after breakfast, lunch, dinner, and at bedtime.
  • Dry the ulcer(s) by gently patting it with a soft, clean cloth.
  • Wash hands before applying.
  • Moisten the tip of the index finger.
  • Squeeze a dab of paste approximately Âŧ inch (0.5 cm) onto a fingertip.
  • Gently dab the paste onto the ulcer. Repeat the process if more than one ulcer are present.
  • Wash hands after application.
  • Wash eyes promptly if they should come in contact with the paste.
  • Use the paste until the ulcer heals. If significant healing or pain relief has not occurred in 10 days, consultation with the physician is required.
  • Contraindications of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Amlexanox oral paste is contraindicated in patients with known hypersensitivity to Amlexanox or other ingredients in the formulation.

  • Side Effects of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Adverse reactions reported by 1-2% of patients were transient pain, stinging and/or burning at the site of application. Infrequent (<1%) adverse reactions in the clinical studies were contact mucositis, nausea, and diarrhea.

  • Pregnancy & Lactation of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

US FDA pregnancy category B. Teratology studies were performed with animals at doses up to two hundred and six hundred times, respectively, the projected human daily dose. No adverse fetal effects were observed. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. Amlexanox was found in the milk of lactating rats; therefore, caution should be exercised when administering Amlexanox oral paste to a nursing woman.

  • Precautions & Warnings of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Wash hands immediately after applying Apsol oral paste directly to ulcers with the finger tips. In the event that a rash or contact mucositis occurs, discontinue use.

  • Use in Special Populations of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Pediatric Use: Safety and effectiveness of Apsol oral paste in pediatric patients have not been established.

  • Overdose Effects of Oral Paste :-Apsol 5% 5gm tube AS A Amlexanox AS A  Corticosteroid, Glucocorticoids).

Ingestion of a full tube of 5 grams of paste would result in systemic exposure well below the maximum nontoxic dose of Apsol in animals. Gastrointestinal upset such as diarrhea and vomiting could result from an overdose.

  •  

āĻ•āĻŋāϛ⧁ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Mouth wash āĻ“ use āĻ•āϰāĻž āĻšāϝāĻŧ ~(Local anestetic Mouth wash )

Oral fresh /Oralon*****

Mouth Wash 3.Oralon 0.2% 100ml Bottle (AS A Chlorhexidine Gluconate AS A Other antibacterial preparation).

Indications

Oralon Mouthwash is an antimicrobial solution which inhibits the formation of dental plaque. It is indicated as an aid in the treatment and prevention of gingivitis and in the maintenance of oral hygiene, particularly in situations where tooth brushing cannot be adequately employed (e.g. following oral surgery, in mentally or physically handicapped patients). It may also be used in a post-peridontal surgery or treatment regimen to promote gingival healing.

Pharmacology

Chlorhexidine is a very potent cationic chemoprophylactic agent that has a broad-spectrum of activity against gm+ve and gm-ve bacteria. It is both bacteriostatic and bactericidal depending on its concentration. The bactericidal effect, which is achieved at high concentrations, is due to the binding of the cationic to negatively charged bacterial cell walls and extramicrobial complexes. Bacteriostatic effect is achieved at low concentrations which causes an alteration of bacterial cell osmotic equilibrium and leakage of potassium and phosphorus.

Dosage & Administration

Adults: Thoroughly rinse the mouth for about one minute with 10 ml twice daily. In the dental surgery the patient should be instructed to rinse the mouth for one minute prior to treatment. Chlorhexidine Gluconate is incompatible with anionic agents which are usually present in conventional dentifrices. These should therefore be used before Chlorhexidine Gluconate (rinsing the mouth between applications) or at a different time of day.

For the treatment of gingivitis a course of about one month is advisable although some variation in response is to be expected. In the case of aphthous ulceration and oral candidal infections treatment should be continued for 48 hours after clinical resolution. For the treatment of dental stomatitis the dentures should be cleansed and soaked in Chlorhexidine Gluconate mouthwash for fifteen minutes twice daily.

Children and the Elderly: The normal adult dose is appropriate for elderly patients and children of 12 years and over unless otherwise recommended by the dentist or the physician. Children under 12 years of age should not use the product unless recommended by a healthcare professional. 

Route of administration: External (oral) use.

Interaction

Oralon is incompatible with anionic agents.

Contraindications

Chlorhexidine Gluconate is contraindicated for patients who have previously shown a hypersensitivity reaction to Chlorhexidine or to any of the excipients in the formulation. However, such reactions are extremely rare.

Side Effects

Discoloration: A superficial discoloration of the dorsum of the tongue may occur. This disappears after treatment is discontinued. Discoloration of the teeth and silicate or composite restorations may also occur. This stain is not permanent and can largely be prevented by reducing the consumption of tea, coffee and red wine and brushing with a conventional toothpaste daily.

Before using the mouthwash or, in the case of dentures, cleaning with a conventional denture cleanser. However, in certain cases a professional prophylaxis (scaling and polishing) may be required to remove this stain completely. Stained anterior toothcoloured restorations with poor margins or rough surfaces which are not adequately cleaned by professional prophylaxis may require replacement. Similarly where normal toothbrushing is not possible, for example with intermaxillary fixation, or with extensive orthodontic appliances, scaling and polishing may also be required once the underlying condition has been resolved. Taste: Transient disturbance of taste sensation and a burning sensation of the tongue may occur on initial use of the mouthwash. These effects usually diminish with continued use. Oral desquamation: In cases where oral desquamation occurs dilution of the mouthwash with an equal volume of tap water, freshly mixed, will often allow continued use of the mouthwash. Parotid gland swelling: Very occasionally, swelling of the parotid glands during the use of chlorhexidine mouthrinses has been reported. In all cases spontaneous resolution has occurred on discontinuing treatment.

Irritative skin reactions: Irritative skin reactions to chlorhexidine preparations can occasionally occur.

Generalised reactions: Allergic reactions, hypersensitivity & anaphylaxis to chlorhexidine have also been reported but are extremely rare.

Pregnancy & Lactation

There is no evidence of any adverse effects on the foetus arising from the use of Chlorhexidine Gluconate during pregnancy or on infants during lactation. Therefore no special precautions are recommended.

Precautions & Warnings

For oral (external) use only. Do not swallow. Keep out of the eyes and ears. If the mouthwash comes into contact with the eyes, wash out promptly and thoroughly with water. In case of soreness, swelling or irritation of the mouth, stop using the product and consult a healthcare professional.

Therapeutic Class

Other antibacterial preparation

NA komle then Antibiotic use korte hobe

āĻ•āĻŋāϛ⧁ 𝐅𝐮𝐧𝐠𝐚đĨ đĸ𝐧𝐟𝐞𝐜𝐭đĸ𝐨𝐧 āĻ āĻĢā§āϞ⧁āϕ⧋āύāĻžāϜāϞ āĻŦ⧇āĻļ āĻ­āĻžāϞ⧋ āĻ•āĻžāϜ āĻ•āϰ⧇â€ĻāĻāχāϟāĻžāϰ Advantage āĻšāϞ⧋ ,āĻāϟāĻŋ 𝐎đĢ𝐚đĨ & 𝐈𝐕 āĻĻ⧁āχāĻ­āĻžāĻŦ⧇āχ āĻĒāĻžāĻ“āϝāĻŧāĻž āϝāĻžāϝāĻŧ & āĻŦāĻžāĻšā§āϚāĻžāĻĻ⧇āϰ āϏāĻŋāϰāĻžāĻĒ āĻ“â€Ļ..Half life āĻ“ āĻŦ⧇āĻļāĻŋ! & Drug Interaction āĻ“ āĻ•āĻŽ!!

āϖ⧁āĻŦ Rarely Liver toxicity āĻ•āϰ⧇āĨ¤ āϤāĻŦ⧇ High Dose āĻ āĻĻāĻŋāϞ⧇ 𝐀đĨ𝐨𝐩𝐞𝐜đĸ𝐞 ,𝐃đĢ𝐲 đĻ𝐨𝐮𝐭𝐡,𝐌𝐞𝐭𝐚đĨđĨđĸ𝐜 𝐭𝐚đŦ𝐭𝐞 āĻšāϤ⧇ āĻĒāĻžāϰ⧇â€Ļ

𝐂đĢ𝐲𝐩𝐭𝐨𝐜𝐨𝐜𝐜𝐚đĨ 𝐌𝐞𝐧đĸ𝐧𝐠đĸ𝐭đĸđŦ āĻ āĻĢā§āϞ⧁āϕ⧋āύāĻžāϜāϞ āϕ⧇ prefer āĻ•āϰāĻž āĻšāϝāĻŧ & Drug Of choice !!

IV route āĻ āĻĻāĻŋāϞ Amphotericin B āĻāϰ āϏāĻŽāĻžāύ Effective ***

𝐂𝐚𝐧𝐝đĸ𝐝𝐞đĻđĸ𝐚 āϤ⧇ ICU āĻĒ⧇āĻļ⧇āĻ¨ā§āϟ āĻĻ⧇āϰ With āύāϰāĻŽāĻžāϞ WBC āĻ•āĻžāωāĻ¨ā§āϟ..(ImmuneSuppressed āύāĻž āĻšāϞ⧇ Candidemia āϤ⧇ āχāωāϏ āĻ•āϰāĻž āĻšāϝāĻŧ..)

Molds & Dimorphic fungi āĻāϰ āĻŦāĻŋāϰ⧁āĻĻā§āϧ⧇ Fluconazole āϤ⧇āĻŽāύ Effactive āύāĻž

āĻĒā§āϰ⧇āĻ—ā§āĻ¨ā§āϝāĻžāϏāĻŋāϰ āϤ⧇ Low Dose āĻ āĻ“ āĻĻ⧇āĻ“āϝāĻŧāĻž āϝāĻžāĻŦ⧇ āύāĻž Miscarriage & Still birth āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Fluconazole āϝ⧇āĻšā§‡āϤ⧁ Liver āϕ⧇ āϤ⧇āĻŽāύ damage āĻ•āϰ⧇ āύāĻž ,āϤāĻžāχ liver Disease āĻ High risk Pt āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Prophylaxis āĻ āĻĒā§āϰ⧇āĻĢāĻžāϰ āĻ•āϰāĻž āĻšāϝāĻŧ Also Allogeneic bone marrow transplants .. āĻāĻ–āύ Posoconazole āĻ“ āĻĻ⧇āϝāĻŧāĻž āĻšāϝāĻŧ..

āĻĢā§āϞ⧁āϕ⧋āύāĻžāϜāϞ prophylaxis in leukemic āĻĒ⧇āĻļ⧇āĻ¨ā§āϟ ;AIDS āĻĒ⧇āĻļ⧇āĻ¨ā§āϟ with low CD4+ T-cell counts, and in patients on surgical intensive care units is controversialâ€Ļ.

Capsule 3:-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Indications of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Flugal is indicated in-

  • Vaginal Candidiasis
  • Oropharyngeal Candidiasis
  • Esophageal Candidiasis
  • Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea
  • Kerion
  • Pityriasis versicolor
  • Onychomycosis
  • Invasive candidal infections and cryptococcal infections (including meningitis)
  • Prevention of cryptococcal meningitis
  • Prevention of fungal infections in immunocompromised patients
  • Systemic Candidiasis and Cryptococcal infection
  • In Superficial Candidiasis
  • In Systemic Candidiasis & Cryptococcal infection

Other indications-

  • Fungal urinary tract infections
  • Disseminated candidiasis
  • Prophylaxis for fungal infection in neutropenic cancer patients.
  • Acute treatment of other systemic fungal infections such as coccidioidomycosis and histoplasmosis.

Pharmacology of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Fluconazole is a triazole antifungal agent. It is a potent inhibitor of fungal cytochrome P-450 dependent enzymes. Cytochrome P-450 enzyme system is essential component of fungal cell membrane which is responsible for the synthesis of ergosterol.

Dosage & Administration of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Adults:

  • Vaginal Candidiasis: 150 mg as a single dose.
  • Oropharyngeal Candidiasis: 200 mg in 1st day followed by 100 mg daily for 14 days.
  • Oesophageal Candidiasis: 200 mg in 1st day followed by 100 mg daily for 14-30 days.
  • Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea: 150 mg weekly for 4-6 weeks.
  • Kerion: 50 mg daily for 20 days.
  • Pityriasis versicolor: 400 mg as a single dose.
  • Onychomycosis: 150 mg weekly for 12 months.
  • Invasive candidal infections and cryptococcal infections (including meningitis): Orally or by IV infusion, 400 mg on first day then 200-400 mg daily.
  • Prevention of cryptococcal meningitis: Orally or by IV infusion 200 mg daily.
  • Prevention of fungal infections in immunocompromised patients: Orally or by IV infusion, 50-400 mg daily.


Child over 1 year-

  • In Superficial Candidiasis: 1-2 mg/kg daily.
  • In Systemic Candidiasis & Cryptococcal infection:3-6 mg/kg daily.

In serious life threatening infections upto 12 mg/kg daily has been given to children aged 5-13 years (Maximum 400 mg daily)

  • 1 year: 9 kg: 1/2 measuring spoonful
  • 1-2 years: 12 kg: 1 measuring spoonful
  • 2-3 years: 14 kg: 1ÂŊ measuring spoonful
  • 3-4 years: 16 kg: 2 measuring spoonful
  • 4-6 years: 20 kg: 2ÂŊ measuring spoonful


Use in Specific Population-

Elderly patient: The normal dose should be used if there is no evidence of renal impairment.

Renal Impairment: No adjustment in single dose therapy is required. In multiple dose therapy of patients with renal impairment, normal doses should be given on days 1 and 2 of treatment and there after the dosage intervals should be modified as follows:

  • Creatinine clearance (>41 ml/min): Dosage interval (hours) 24
  • Creatinine clearance (21-40 ml/min): Dosage interval (hours) 48
  • Creatinine clearance (10-20 ml/min): Dosage interval (hours) 72
  • Patients receiving regular dialysis: One dose after every dialysis session

Children: Renal clearance in children may be proportionately more rapid than in adults and doses up to 12 mg/kg is recommended.

Side Effects of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Flugal is generally well tolerated. The commonest side-efects associated Flugal are symptoms associated with the gastrointestinal tract; these include nausea, abdominal discomfort, diarrhoea and fatulence. Other adverse events such as rash are rarely encountered (Incidence less than 1%). In rare cases, as with other azoles, anaphylaxis has been reported.

Pregnancy & Lactation of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Fluconazole adverse fetal efects have been seen in animals only at dose levels associated with maternal toxicity. These levels are many times in excess of those recommended for therapeutic use. There has been little use during human pregnancy. Accordingly, fuconazole should not be used in pregnancy or in women of child bearing potential unless adequate contraception is employed.

Therapeutic Class of Capsule :-Flugal 150mg (AS A Fluconazole AS A Drugs for subcutaneous and mycoses).

Drugs for subcutaneous and mycoses

4.āϏāĻžāϝāĻŧāĻžāύ⧋-āϕ⧋āĻŦāĻžāϞāĻžāĻŽāĻŋāύ (Cyanocobalamin) – āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ B12 Supplement:-

Tablet 4.Mecolagin 500 Mcg chewable Tablet AS A Mecobalamin Drugs for Megaloblastic Anemia. With +

Vitamin B complex, Tablet :-Solvit -B AS A Vitamin B-Complex AS A (5mg+2mg+2mg +20mg) AS A Specific combined vitamin preparations

āĻŦ⧇āĻžā§āĻœā§‹āϕ⧇āχāύ (Benzocaine) – āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ• (Topical Analgesic):-

5.Topical Ointment :-Dentogel, OR Oragel

  • āĻĻā§āĻŦāĻžāϰāĻž āĻŦā§āϝāĻŦāĻšā§ƒāϤ: āφāϞāϏāĻžāϰ⧇āϰ āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽā§‡āϰ āϜāĻ¨ā§āϝāĨ¤
  • āĻĄā§‹āϜ: āĻĻāĻŋāύ ā§Š-ā§Ē āĻŦāĻžāϰ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ¸ā§āĻĨāĻžāύ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰ⧁āύāĨ¤
  • āĻ…āĻŦāĻ¸ā§āĻĨāĻž: āĻŽāϞāĻŽ āφāĻ•āĻžāϰ⧇āĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻ…āĻžā§āϚāϞ⧇ āĻŽāϞāĻŽ āϞāĻžāĻ—āĻŋāϝāĻŧ⧇ ⧍-ā§Š āĻŽāĻŋāύāĻŋāϟ āĻ…āĻĒ⧇āĻ•ā§āώāĻž āĻ•āϰ⧁āύ, āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āφāϗ⧇ āĻāĻŦāĻ‚ āĻĒāϰ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰ⧁āύāĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āϖ⧁āĻŦ āĻĻā§€āĻ°ā§āϘāĻ•āĻžāϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĨ⧇āϕ⧇ āϏāĻ‚āĻŦ⧇āĻĻāύāĻļā§€āϞāϤāĻž āĻŦāĻž āĻ¤ā§āĻŦāϕ⧇ āĻœā§āĻŦāĻžāϞāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϞāĻŋāĻĄā§‹āϕ⧇āχāύ (Lidocaine) – Local Anesthetic:–

7. Gel Xylogel 2% 30gm tube AS A Lidocaine Hydrochloride Local & Surface anesthesia.

  1. āĻŦā§āϝāĻŦāĻšāĻžāϰ: āĻāϟāĻŋ āĻāĻ•āϟāĻŋ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ āĻ¸ā§āĻĨāĻžāύ⧀āϝāĻŧ āĻ…ā§āϝāĻžāύāĻžāϞāĻœā§‡āϏāĻŋāĻ•, āϝāĻž āĻŦā§āϝāĻĨāĻž āωāĻĒāĻļāĻŽ āĻ•āϰāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤āĻŽā§‡āĻ•āĻžāύāĻŋāϜāĻŽ: āĻ¸ā§āύāĻžāϝāĻŧ⧁ āϤāĻ¨ā§āϤ⧁āϤ⧇ āĻĒā§āϰāĻ­āĻžāĻŦ āĻĢ⧇āϞ⧇ āĻāĻŦāĻ‚ āĻŦā§āϝāĻĨāĻž āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇āĨ¤

💊 āĻĄā§‹āϜ / āĻĒā§āϰāϝāĻŧā§‹āĻ—āĻŦāĻŋāϧāĻŋ

  • Gel ulcer āĻāϰ āωāĻĒāϰ āϏāϰāĻžāϏāϰāĻŋ āĻĒāĻžāϤāϞāĻž āĻ¸ā§āϤāϰ⧇ āϞāĻžāĻ—āĻžāϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻĻāĻŋāύ⧇ ā§¨â€“ā§Š āĻŦāĻžāϰ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇, āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻ–āĻžāĻŦāĻžāϰ āĻ–āĻžāĻ“āϝāĻŧāĻžāϰ āφāϗ⧇āĨ¤
  • āĻāĻ•āĻŦāĻžāϰ⧇ āĻŽāϟāϰāĻĻāĻžāύāĻžāϰ āϏāĻŽāĻžāύ (pea-sized) āĻĒāϰāĻŋāĻŽāĻžāĻŖ āϝāĻĨ⧇āĻˇā§āϟāĨ¤
  • āĻĒā§āϰāϝāĻŧā§‹āϗ⧇āϰ āĻĒāϰ āĻ…āĻ¨ā§āϤāϤ ā§Šā§Ļ āĻŽāĻŋāύāĻŋāϟ āĻ–āĻžāĻ“āϝāĻŧāĻž-āĻĻāĻžāĻ“āϝāĻŧāĻž āĻāĻĄāĻŧāĻŋāϝāĻŧ⧇ āϚāϞāĻž āĻ­āĻžāϞ⧋, āϝāĻžāϤ⧇ āĻ“āώ⧁āϧ āĻ•āĻžāϜ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

âš ī¸ āϏāϤāĻ°ā§āĻ•āϤāĻž

  • āĻāϟāĻŋ āĻļ⧁āϧ⧁ āĻŦā§āϝāĻĨāĻž āĻ•āĻŽāĻžāĻŦ⧇, āĻ•āĻŋāĻ¨ā§āϤ⧁ ulcer āĻāϰ āĻŽā§‚āϞ āĻ•āĻžāϰāĻŖ āϏāĻžāϰāĻžāĻŦ⧇ āύāĻžāĨ¤
  • āĻŦ⧇āĻļāĻŋ āĻĒāϰāĻŋāĻŽāĻžāϪ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāϞ⧇ āϜāĻŋāĻšā§āĻŦāĻž/āĻ—āϞāĻž āĻ…āϏāĻžāĻĄāĻŧ āĻšāϝāĻŧ⧇ āĻ—āĻŋāϞāϤ⧇ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻļāĻŋāĻļ⧁āĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻŦāĻŋāĻļ⧇āώ āϏāϤāĻ°ā§āĻ•āϤāĻž āĻĒā§āϰāϝāĻŧā§‹āϜāύāĨ¤
  • āϝāĻĻāĻŋ āĻŦāĻžāϰāĻŦāĻžāϰ ulcer āĻšāϝāĻŧ āĻŦāĻž ⧍ āϏāĻĒā§āϤāĻžāĻšā§‡āĻ“ āύāĻž āϏāĻžāϰ⧇ → āĻĄāĻžāĻ•ā§āϤāĻžāϰāϕ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āϜāϰ⧁āϰāĻŋ, āĻ•āĻžāϰāĻŖ āĻāϟāĻŋ recurrent aphthous ulcer, nutritional deficiency, āĻŦāĻž systemic āϰ⧋āϗ⧇āϰ āĻ…āĻ‚āĻļ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻĒā§āϰ⧇āĻĄāύāĻŋāϏ⧋āϞ⧋āύ (Prednisolone) – Corticosteroid:

8.Tablet :-Cortan 10 mg AS A Prednisolone AS A Glucocorticoids

OR Cream Pevisone (1%+0.1%) 10gm tube AS A (Econazole Nitrate +Triamcinolone Acetonide) AS A Triamcinolone & Combined preparations.

  • āĻĄā§‹āϜ: 5mg āĻĒā§āϰāϤāĻŋāĻĻāĻŋāύ ā§§āϟāĻŋ āĻŸā§āϝāĻžāĻŦāϞ⧇āϟ, ā§Ģ-ā§­ āĻĻāĻŋāύāĨ¤
  • āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻĒāĻĻā§āϧāϤāĻŋ: āĻ–āĻžāĻŦāĻžāϰ⧇āϰ āĻĒāϰ⧇ āϏ⧇āĻŦāύ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤
  • āĻĒāĻžāĻ°ā§āĻļā§āĻŦāĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž: āĻĻā§€āĻ°ā§āϘāĻŽā§‡āϝāĻŧāĻžāĻĻā§€ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻ¸ā§āύāĻžāϝāĻŧ⧁āϰ āĻ•ā§āώāϤāĻŋ, āĻ“āϜāύ āĻŦāĻžāĻĄāĻŧāĻžāύ⧋, āĻšāϜāĻŽ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

Oral Gel 9.Bongel (0.01%+8.714%) 10gm tube AS (A Cetalkonium Chloride +Choline Salicylate) AS A Non-steroidal Anti-inflammatory Drugs (NSAIDs), Preparations for Oral Ulceration & Inflammation

Raiyyan Tahsan Date:13-08-2025 Wednesday Time:04-07-55 PM

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top